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1Abbreviations
ALL acute lymphoblastic leukemia
ATP adenosine triphosphate
BAC bacterial artificial chromosome
CTP cytidine triphosphate
DAPI 4',6-diamidino-2-phenylindole
DMEM Dulbecco's modified Eagle's medium
dNTP deoxyribonucleotide triphosphate
ds double-stranded
DTT dithiothreitol
EDTA ethylenediaminetetraacetic acid
EGFP enhanced green fluorescent protein
esiRNA endoribonuclease-prepared short interfering RNA
FBS fetal bovine serum
FSC forward scatter
FSG fish skin gelatine
GFP green fluorescent protein
GST glutathione S-transferase
GTP guanosine triphosphate
Kan kanamycin
Neo neomycin
ORF open reading frame
PBS phosphate buffered saline
PFA paraformaldehyde
PI propidium iodide
PRC pre-replicative complex
qRT-PCR quantitative reverse transcription PCR
RFP red fluorescent protein
RISC RNA induced silencing complex
RNAi RNA interference
shRNA short hairpin RNA
siRNA short interfering RNA
TAP tandem affinity purification
UTP uridine triphosphate
UTR untranslated region
2Summary
The eukaryotic cell cycle orchestrates the precise duplication and distribution of
the genetic material, cytoplasm and membranes to daughter cells. In multicellular
eukaryotes, cell cycle regulation also governs various organisatorial processes
ranging from gametogenesis over multicellular development to tissue formation
and repair. Consequently, defects in cell cycle regulation provoke a variety of
human cancers. A global view of genes and pathways governing the human cell
cycle would advance many research areas and may also deliver novel cancer
targets. Therefore this work aimed on the genome-wide identification and
systematic characterisation of genes required for cell cycle progression in human
cells.
I developed a highly specific and efficient RNA interference (RNAi)
technology to realize the potential of RNAi for genome-wide screening of the
genes essential for cell cycle progression in human tissue culture cells. This
approach is based on the large-scale enzymatic digestion of long dsRNAs for the
rapid and cost-efficient generation of libraries of highly complex pools of
endoribonuclease-prepared siRNAs (esiRNAs). The analysis of the silencing
efficiency and specificity of esiRNAs and siRNAs revealed that esiRNAs are as
efficient for mRNA degradation as chemically synthesized siRNA designed with
state-of-the-art design algorithms, while exhibiting a markedly reduced number of
off-target effects.
After demonstrating the effectiveness of this approach in a proof-of-
concept study, I screened a genome-wide esiRNA library and used three assays
to generate a quantitative and reproducible multi-parameter profile for the 1389
identified genes. The resulting phenotypic signatures were used to assign novel
cell cycle functions to genes by combining hierarchical clustering, bioinformatics
and proteomic data mining. This global perspective on gene functions in the
human cell cycle presents a framework for the systematic documentation
3necessary for the understanding of cell cycle progression and its misregulation in
diseases.
The identification of novel genes with a role in human cell cycle
progression is a starting point for an in-depth analysis of their specific functions,
which requires the validation of the observed RNAi phenotype by genetic rescue,
the study of the subcellular localisation and the identification of interaction
partners of the expressed protein. One strategy to achieve these experimental
goals is the expression of RNAi resistant and/or tagged transgenes. A major
obstacle for transgenesis in mammalian tissue culture cells is the lack of efficient
homologous recombination limiting the use of cultured mammalian cells as a real
genetic system like yeast. I developed a technology circumventing this problem
by expressing an orthologous gene from a closely related species including its
regulatory sequences carried on a bacterial artificial chromosome (BAC). This
technology allows physiological expression of the transgene, which cannot be
achieved with conventional cDNA expression constructs. The use of the
orthologous gene from a closely related species confers RNAi resistance to the
transgene allowing the depletion of the endogenous gene by RNAi. Thus, this
technology mimics homologous recombination by replacing an endogenous gene
with a transgene while maintaining normal gene expression. In combination with
recombineering strategies this technology is useful for RNAi rescue experiments,
protein localisation and the identification of protein interaction partners in
mammalian tissue culture cells.
In summary, this thesis presents a major technical advance for large-scale
functional genomic studies in mammalian tissue culture cells and provides novel
insights into various aspects of cell cycle progression.
4Chapter 1: Introduction
The mitotic cell cycle
Principles
Every cell reproduces by duplicating its genetic material and cell content, and
then dividing. In eukaryotes, duplication and division occurs in a complex and
highly regulated manner to precisely pass the entire genome from one cell to its
daughter cells. This is achieved by the accurate replication of the chromosomes
in the nucleus and the subsequent distribution of one set of chromosomes to
each of the two daughter cells during cell division. To maintain the size of the
genome, DNA replication in somatic cells is strictly linked to cell division. The
resulting alternation between replication and division creates the mitotic cell
cycle.
The mitotic cell cycle is divided into four phases: DNA replication is
executed during S (synthesis) phase, and the equal distribution of the replicated
sister chromatids of the chromosomes occurs in M (mitosis) phase, during which
the chromosomes condense, congress and segregate to two opposite cell poles
by a microtubule-based structure, the mitotic spindle. In most cell types, mitosis
is finished by cytokinesis, i.e. the cytoplasmic division that provides each
daughter cell with organelles.
In between these two phases cells prepare themselves for the successful
completion of the S and M phases, respectively or repair DNA damage and
replication errors. These are the first gap or G1 phase (between M and S phase)
and the second gap or G2 phase (between S and M phase). Cells can also
cease cell cycle progression in G1 permanently because of the absence of
positive or the presence of negative regulatory signals and enter a non-dividing
state known as G0.
5Transition between G1, S, G2 and M phase is tightly controlled by
checkpoints, which actively halt progression through the cell cycle until the
accurate completion of a phase. This regulatory system that ensures the proper
progression through the cell cycle is mainly orchestrated by cyclin-dependent
kinases (Cdks) and ubiquitin ligases. These two different enzyme classes
represent two recurrent themes in cell cycle regulation, which are the rapid
protein (in)activation through the change of the phosphorylation status by kinases
and the removal of proteins through ubiquitin-mediated degradation in the
proteasome that is triggered through polyubiquitination by ubiquitin ligases. The
activity of Cdks is controlled by their phosphorylation status and by association
with specific regulatory subunits, the cyclins. Likewise, ubiquitin ligases are
regulated by phosphorylation and binding of regulatory subunits.
This work focused on the study of cell cycle progression in human tissue
culture cells, in particular I was interested in cell division. Therefore, I will briefly
describe in the following four sections the major cell cycle events from the
perspective of human cells and provide a more detailed overview of mitosis and
cytokinesis. Much of the current knowledge described below resulted from
pioneering work in yeast and other model organisms reflecting the evolutionary
conservation of the basic organisation of the cell cycle in all eukaryotic cells from
yeast to human cells.
G1 regulation and G1/S transition
During the G1 phase the integration of many signals, such as metabolic, stress
and environmental cues governs whether a cell enters S phase to self-renew or
pauses to rest or to differentiate.
In early G1, mitogenic signals increase the amount of D-type cyclins,
which bind to Cdk4 and Cdk6 to phosphorylate the retinoblastoma protein (Rb) or
its family members p107 and p130. Phosphorylation dissociates Rb from E2F
transcription factors and enables thereby the transcription of a large set of
6components required for DNA replication and subsequent cell cycle events
(Weinberg, 1995). Once the execution of the E2F-transcriptional program has
started the cells have passed the restriction point, which commits them to a
round of DNA replication and division. In particular, E2F governs the transcription
of E- and A-type cyclins that bind to Cdk2, which is a key regulator for G1/S
progression. CyclinE/A-Cdk2 is activated by the removal of an inhibitory
phosphorylated site by the phosphatase Cdc25A (Murray, 2004). Activated
CyclinE/A-Cdk2 triggers entry into S phase by initiating DNA replication through a
mechanism that will be described in the following section.
There are various signaling and regulatory pathways that influence G1
progression and G1/S transition, e.g. growth factor signaling via the Ras–MEK-
ERK kinase cascade terminally phosphorylates and stabilizes the transcription
factor c-Myc that induces the expression of D-type cyclins. At the same time, c-
Myc inhibits the expression of p15, p21 and p27, which bind and inactivate
Cyclin-Cdks. These Cdk inhibitors are expressed upon TGF-β-SMAD signaling
(p15), oxidative stress and starvation signals via FOXO-governed transcription
(p21, p27), or p53 activation (p21) that can follow e.g. upon DNA damage
(Massague, 2004). These inhibitory pathways can lead to a permanent
withdrawal from the cell cycle and entry into G0 before the restriction point has
been passed or they prevent temporarily the entry into S phase in late G1.
S phase (DNA replication)
Progression through S phase requires accurate DNA replication to ensure that
the entire genome is duplicated exactly once without errors in a timely fashion.
Therefore cells license DNA replication and check the fidelity of replication by a
system that can detect replication errors and DNA damage to initiate DNA repair.
All eukaryotic cells initiate replication from multiple replication origins
spread over the chromosomes. G1/S transition that is regulated by Cdk2 involves
the conversion of pre-replicative complexes (PRCs) into replication forks.
7Formation of PRCs starts in late M and early G1 phase with the binding of six
proteins to the replication origins that form the origin recognition complex (ORC).
This complex recruits the kinase Cdc6 and Cdt1 (Cdc10-dependent transcript 1)
that subsequently load the Mcm(minichromosome maintenance)2-7 complex,
which functions as a DNA helicase during replication. Initiation of replication (also
known as origin firing) begins with the binding of Mcm10 to the PRC that recruits
in a Cdk2- and Cdc7/Ask (Activator of S phase kinase)-dependent manner
Cdc45l (Cdc45-like), which is essential for origin unwinding and loading of the
DNA polymerases alpha (POLA), delta (POLD) and epsilon (POLE). POLA
synthesizes short RNA primers that are used for elongation by POLD and POLE.
POLD and POLE are kept on the DNA by a sliding clamp formed by the protein
PCNA (proliferating cell nuclear antigen) (Kelly and Brown, 2000).
Cdk2 does not only initiate replication but also ensures that replication
starts only once from one replication origin (replication licensing) by
phosphorylation of Cdc6 and Mcm proteins, which promotes dissociation of Cdc6
from ORC, ubiquitination of Cdc6, inhibition of Cdc6 and Mcm2-7 reassembly at
other origins and nuclear export of Mcm proteins. After S phase the replication
licensing function is maintained by the protein geminin and Cdk1 until the end of
mitosis, when formation of novel PRC starts (Kelly and Brown, 2000; Takeda and
Dutta, 2005).
Errors during DNA replication or DNA damage during S phase activate an
intra-S-phase checkpoint that inhibits the firing from replication origins that have
not been initiated. The upstream mediator of this response is the kinase ATR.
ATR activates Chk1 that phosphorylates Cdc25A, which is the activator of Cdk2.
The resulting inhibition of Cdk2 blocks the loading of Cdc45l and thereby inhibits
the initiation of replication. A second response mediated by the kinase ATM
leads to the phosphorylation of the cohesin protein SMC1. In addition to
checkpoint activation, DNA repair is triggered by ATR (upon stalling of replication
forks) and ATM (upon DNA lesions), which are recruited to the site of damage,
where they phosphorylate various substrates required for protecting the integrity
8of stalled replication forks and the induction of DNA repair (Bartek et al., 2004;
Gottifredi and Prives, 2005; Kelly and Brown, 2000).
Another important event in S phase in addition to DNA replication is the
duplication of the centrosome, which is a major microtubule organising centre in
all animal cells. During mitosis the two centrosomes that originated from
centrosome duplication nucleate an array of microtubules, the mitotic spindle,
and thereby define the poles of the spindle, which will be described in more detail
below. During cell division the two centrosomes are partitioned like the
chromosomes so that each daughter cell receives a centrosome that must be
duplicated before entering mitosis. This alternation between centrosome
duplication and partitioning creates in analogy to the cell cycle the centrosome
cycle in animal cells (Doxsey, 2001; Meraldi and Nigg, 2002).
G2 regulation and G2/M transition
After completing S phase cells progress through the G2 phase during which they
prepare themselves for mitosis and cytokinesis by expressing genes required for
these processes. For example, B-type cyclins, which bind to the major regulator
of mitosis Cdk1, are expressed during G2. Entry into mitosis is triggered by the
activation of CyclinB(A)-Cdk1 through dephosphorylation by the phosphatase
Cdc25C. This activating dephosphorylation occurs when the activity of Cdc25C
towards Cdk1 exceeds that of the opposing kinases Wee1 and Myt1 and marks
G2/M transition. An important regulator of this process is Plk1 (polo-like kinase
1), which phosphorylates Cdc25C, Wee1 and Myt1. The phosphorylation of
Cdc25C by PLK1 leads to its activation, whereas the phosphorylation of Wee1 or
Myt1 triggers ubiquitination and degradation or inactivation, respectively (van
Vugt and Medema, 2005).
In response to DNA damage and incomplete DNA replication, checkpoints
delay cell cycle progression in G2. Cdc25C and Plk1 are targets of these
9checkpoints. Unreplicated or damaged DNA induces the ATM/ATR signaling
pathways, which lead to inhibition of Plk1 (Smits et al., 2000). Chk2, which is
activated by ATM/ATR inactivates Cdc25C through phosphorylation (Matsuoka et
al., 1998).
M phase (mitosis and cytokinesis)
The main function of mitosis is to equally distribute sister chromatids
(chromosome segregation) into two daughter cells to ensure that each daughter
cell obtains a complete set of chromosomes. Mitosis or nuclear division is
typically immediately followed by cytokinesis, the division of the cytoplasm, which
supplies the two nascent daughter cells with a nucleus and organelles. The
temporal and spatial organisation of mitosis requires chromosome condensation
and the assembly of the mitotic spindle, whereas cytokinesis depends on the
concerted action of the spindle, the actomyosin cytoskeleton and the cell cortex.
In early mitosis (prophase), interphase chromatin undergoes extensive
changes triggered by Topoisomerase II and condensins that lead to
condensation of chromatin resulting in the formation of mitotic chromosomes,
which is accompanied by histone phosphorylation, e.g. of the core histone H3
(Swedlow and Hirano, 2003). At the same time, duplicated centrosomes separate
and migrate apart, which define later in mitosis the spindle poles. Centrosome
separation is triggered by the kinase Nek2 and requires the activity of the
kinesin-like motor protein KIF11, which is recruited to centrosomes upon Cdk1
phosphorylation (Meraldi and Nigg, 2002).
Next, with the onset of prometaphase the nuclear envelope breaks down
(NEBD) as a consequence of hyperphosphorylation of proteins of the lamina
underlying the nuclear envelope (lamins) by Cdk1 (Lenart and Ellenberg, 2003).
The chromosomes can then attach to microtubules nucleated from each of the
centrosomes grown toward the chromosomes via kinetochores that are
multiprotein assemblages associated with centromers of mitotic chromosomes. In
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addition to that, mitotic chromosomes can act as microtubule organising centres
by using a Ran-GTP gradient around the chromosomes that locally promotes
microtubule polymerization (Heald et al., 1997; Hetzer et al., 2002). The
assembly of the bipolar spindle and the attachment of the microtubules to the
kinetochores is a dynamic process that relies on the dynamic instability of
microtubules, which is regulated by microtubule stabilizing (causing rescue) and
destabilizing proteins (causing catastrophes) and on microtubule-dependent
motor proteins. The activity of these proteins is primarily controlled by
phosphorylation, e.g. through Cdk1 and PLK1. Microtubules that attach through
their plus ends to the kinetochore of a chromosome become stabilized, so that
they no longer undergo catastrophes (Wittmann et al., 2001).
The eventual interaction of paired sister chromatids with microtubules
nucleated from the two spindle poles results in a stable, bipolar attachment.
When this process is completed for all chromosomes, they have congressed to
an equatorial plane, which defines the onset of metaphase. After all
chromosomes have undergone bipolar attachment, a sudden loss in sister-
chromatid cohesion triggers the onset of anaphase. Sister chromatids are then
pulled towards the poles and the poles themselves separate further towards the
cell cortex. Sister-chromatid separation depends on the degradation of an
inhibiting protein, securin, by ubiquitin-dependent proteolysis. This inhibitor
prevents a protease, separase, from abolishing sister-chromatid cohesion by
cutting a component of a multiprotein complex known as cohesin that glues the
two sister chromatids together (Uhlmann, 2003). Ubiquitination of securin is
mediated by the Anaphase promoting complex (APC) (Nasmyth, 2005). This
complex does not only trigger the destruction of anaphase onset inhibitors but
also of mitotic cyclins (cyclin A and B) and mitotic kinases (PLK1, Nek2, Aurora
kinases) and therefore promotes mitotic exit. The ubiquitination of different
substrates by APC is temporarily highly regulated, because two forms of APC are
activated sequentially by the association of the two activators Cdc20 and Cdh1,
respectively. APC-Cdc20 is active at the metaphase–anaphase transition, and
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APC-Cdh1 is turned on later in mitosis but then remains active throughout the
subsequent G1 phase (Fung and Poon, 2005).
Anaphase onset is prevented as long as chromosomal kinetochores are
not correctly attached by a mechanism known as the spindle assembly
checkpoint. This checkpoint monitors the attachment of microtubules to
kinetochores and/or the generation of tension that results from bipolar
attachment of sister chromatids. Structural changes induced by microtubule
attachment and/or tension cause a conformational change of Mad2 that can then
bind Cdc20. Unattached kinetochores therefore function as sites of continuous
assembly and release of Mad2–Cdc20 complexes that prevent the activation of
APC-Cdc20. On attachment of the last kinetochore, the production of inhibitory
Mad2–Cdc20 complexes ceases, allowing Cdc20 to dissociate from Mad2 and
activates APC, which triggers the onset of anaphase (Nasmyth, 2005).
Once the chromosomes have arrived at the spindle poles in telophase, a
nuclear envelope re-assembles around each of the two sets of segregated
chromosomes, and chromatin decondensation begins. At this stage cells start to
assemble a cleavage furrow, which is formed by a contractile actomyosin ring at
the cell cortex that constricts the plasma membrane to generate two daughter
cells connected by a midbody that is finally severed to complete cell division.
This process, cytokinesis, requires the accurate timing and positioning of
contractile ring assembly and cleavage furrow ingression (Glotzer, 2005). The
induction of the cleavage furrow is dependent on the mitotic spindle in anaphase,
in particular central spindle and astral microtubules were found to play an
essential role for this process (D'Avino et al., 2005). The assembly of the central
spindle requires a protein complex consisting of the kinesins MKLP1/2 and the
Rho-GTPase-activating protein MgcRacGAP. The recruitment of these proteins
requires the two chromosomal passenger proteins INCENP and Aurora B, Plk1,
the kinesins KIF4 and KIF18, and the microtubule-associated protein PRC1. The
assembly of the contractile ring is directed by RhoA, which induces actin
nucleation and myosin activation on a scaffold of septins and the actin-binding
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protein anillin. RhoA is activated by the RhoGEF Ect2 and regulates actomyosin
dynamics through activation of the kinases ROCK1 and CIT, which
phosphorylate the regulatory light chain of myosin and through activation of
proteins that induce actin polymerization (D'Avino et al., 2005; Glotzer, 2005).
Functional analysis of cell cycle progression
Genetic approaches to study cell cycle progression
The regulation of the cell cycle influences all aspects of multicellular organisation
in animals, particularly development relies on tightly coordinated proliferation.
Similarly, homeostasis and regeneration rely on accuracy of cell cycle regulation.
Given the central importance of the cell cycle in the coordination of multicellular
organisation, defective cell cycle regulation provokes disease, particularly
leukemias and other cancers. Thus the study of the molecular mechanisms
underlying cell cycle regulation does not only help to understand a fundamental
biological process but has also a profound impact on the diagnosis and the
treatment of human cancer diseases.
For these reasons, the cell cycle has been extensively studied over the
years as one of the major fields of interest in biomedical research. The current
knowledge of the cell cycle originated to a large extent from genetic studies, in
particular loss-of-gene function studies that have identified genes and
mechanisms functioning in the cell cycle. In yeast, where gene inactivation can
be easily achieved and analysed, this approach has provided fundamental
insights into the regulation of the cell cycle, most notably the role of cyclins and
cyclin-dependent kinases (Hartwell, 1991; Nurse, 2000). In multicellular
eukaryotes, the identification of natural mutants or randomly mutagenized
individuals with a cell cycle defect, e.g. in D. melanogaster and C. elegans and
the subsequent identification of the affected genes has uncovered important
players in the cell cycle (Karess et al., 1991; Smith et al., 1985). Although these
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forward genetic approaches have been useful for the identification of gene
functions they do not allow to uncover all cell cycle-associated genes of a
genome, e.g. when a mutation would cause lethality or could be compensated
during development and are relatively laborious. Alternatively, approaches that
enable the identification of gene functions by studying phenotypic changes after
directed gene inactivation can uncover genes that are not practically accessible
with forward genetics. For reverse genetic approaches, the completion of the
sequencing of the human genome and the genomes of other model organism
has identified most, if not all, existing genes thereby providing a large set of
genes that could be screened for a role in cell cycle regulation.
The identification of genes essential for cell cycle progression by large-
scale reverse genetic studies was for a long time only possible in yeast because
of its powerful genetics that relies on the use of efficient homologous
recombination in a haploid organism (Klinner and Schafer, 2004). In multicellular
eukaryotes, such analyses were hampered by the lack of a comparable
technology. Although homologous recombination-based techniques have been
developed for gene targeting e.g. in murine stem cells and were also used for the
study of cell cycle regulators, homologous recombination did not prove to be
efficient enough in animals for large-scale use. Several technologies, e.g.
ribozyme/antisense approaches (Scherer and Rossi, 2003), protein depletion
through the injection of blocking antibodies into cells (Lamb et al., 1996) and
small molecule protein inhibitors (Peterson and Mitchison, 2002) were previously
used as alternative tools for perturbation of gene functions. However, all of these
approaches did either not demonstrate the robustness needed for general use in
functional studies (e.g. antisense or ribozyme technologies) or are only available
and useful for a small number of proteins (e.g. antibodies and small molecule
inhibitors).
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RNA interference
A turning point for large-scale functional studies in animals was the discovery
that long double-stranded (ds)RNA triggers potent and specific mRNA
degradation in C. elegans through the evolutionarily conserved RNA interference
(RNAi) pathway (Fire et al., 1998). Because long dsRNA can be easily and
reproducibly synthesized and introduced into C. elegans RNAi became soon a
standard method and rose rapidly from single-gene to full genome functional
studies in this model organism (Fraser et al., 2000; Gonczy et al., 2000; Kamath
et al., 2003; Sonnichsen et al., 2005). While this approach proved successful in
other model organisms such as D. melanogaster (Kennerdell and Carthew,
1998), the use of long dsRNAs for RNAi in most mammalian cells was hampered
by the induction of a strong, non-specific interferon response by dsRNAs > 30 bp
(Stark et al., 1998). The analysis of the molecular mechanism of RNAi revealed
that long dsRNA is cleaved by the RNase III-like enzyme Dicer into 21-23 nt
short interfering (si)RNAs, which are the ultimate mediators of RNAi (Elbashir et
al., 2001b). Further analyses revealed that siRNAs are targeted to the RNA
induced silencing complex (RISC) (Martinez et al., 2002), where they are
unwound by the Argonaute2 protein (Meister et al., 2004). If the antisense strand
is loaded into RISC it triggers degradation of (partially) complementary mRNA.
Thus, siRNAs elicit mRNA degradation without inducing the interferon pathway
and have therefore enabled the use of RNAi as a functional genomic tool in
mammals.
For mammalian RNAi experiments a range of technologies that closely
mimics the endogenous Dicer cleavage products has been developed. Today,
the most commonly used approaches are chemically synthesized siRNAs
(Elbashir et al., 2001a), which were historically the first RNAi reagents introduced
for mammalian tissue culture cells and vector-expressed short hairpin (sh)RNAs
that are converted intracellularly into siRNAs (Brummelkamp et al., 2002).
Several large-scale libraries for the human and mouse genomes have been
recently generated with these two technologies and have been made available
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through a number of suppliers (Echeverri and Perrimon, 2006). Both, siRNA and
shRNA libraries require the synthesis of either RNA or DNA oligonucleotides that
are transfected directly, or first cloned into an expression vector, respectively.
Both approaches have advantages and disadvantages depending on the
experimental context and the price aspect (Echeverri and Perrimon, 2006).
An important requirement for any large-scale RNAi study is a high
knockdown efficiency for each individual silencing trigger in a library. For this
purpose, the most recently released siRNA and shRNA libraries have used
design algorithms that are based on thermodynamic and sequence-specific
properties to predict efficient silencing molecules (Boese et al., 2005; Silva et al.,
2005). While the use of these algorithms has improved the overall silencing
efficacy, no prediction algorithm exists yet that can exclude off-target gene
silencing, which has been recently recognized as a major challenge for the
reliability of data generated in screen using siRNAs or shRNAs (Jackson et al.,
2003; Lin et al., 2005). Detailed analyses revealed that siRNAs and shRNAs
downregulate in addition to their specific targets numerous unintended transcripts
with limited sequence complementarity to the specific siRNA target sequence
(Birmingham et al., 2006; Jackson et al., 2006), which makes the design of
specific silencing molecules difficult if not impossible. Therefore, approaches that
would provide cheaper and more specific RNAi reagents in large scale would
serve the cell cycle field and the cell biology community in general.
Transgenesis in tissue culture cells
RNAi is a powerful tool to identify gene functions in mammalian tissue culture
cells based on the analysis of the knockdown phenotype. However, RNAi has
produced a new set of problems in determining the specificity of the altered
phenotype because of off-target effects that challenge the reliability of RNAi in
loss-of-function studies. Control experiments are therefore important to confirm
the specificity of an RNAi phenotype (Editorial, 2003; Hannon and Rossi, 2004).
The ultimate way to be sure of the specificity of a loss-of-function phenotype is a
rescue experiment. In order to perform such an experiment in mammalian cells,
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the reintroduced gene must be resistant to the trigger dsRNA. Ideally, this rescue
gene should also be expressed within the physiological range.
Once the specificity of an RNAi phenotype has been verified a putative
function can be assigned to a gene with high confidence. The next task is to
integrate this function into a molecular and cellular context that can be achieved
by analysing the subcellular localisation and the identification of interaction
partners of the expressed protein. Two technologies have been established for
this purpose that can be performed at large scale. For the analysis of protein
localisation fluorescent reporters such as the green fluorescent protein (GFP) are
tagged to the protein of interest (Chalfie et al., 1994). In contrast to
immunostaining that relies on the availability of a specific antibody, this approach
can also be used for imaging of living cells, which has revolutionized light
microscopical analyses in cell cycle processes. In particular, the direct
observation of fluorescently tagged cytoskeletal and chromosomal proteins in
living cells has furthered the understanding of the dynamics of cell division
(Rieder and Khodjakov, 2003). For the identification of proteins that form stable
complexes with the analysed protein, tandem affinity purification strategies have
been developed that allow the purification of protein complex. This approach is
based on the expression of proteins appended with affinity tags that are used for
affinity chromatography (Rigaut et al., 1999). Subsequently, the components of
the purified complexes can be determined by mass spectrometry.
In yeast, phenotypic rescue and the identification of the localisation and
the interaction partners of proteins can be easily achieved using homologous
recombination, thereby ensuring physiological expression of the modified genes.
The ease of this approach has enabled genome-wide tagging projects to localise
most yeast proteins to their specific compartments (Huh et al., 2003) and for the
global identification of protein complexes (Gavin et al., 2006; Krogan et al.,
2006).
The lack of efficient homologous recombination in mammals makes this
genetic approach unpractical in mammalian tissue culture cells. Therefore
alternative methods have been developed for generating cell lines that
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constitutively express RNAi resistant and/or tagged transgenes using cDNA
constructs ectopically expressed from a plasmid (Lassus et al., 2002; Wadsworth
et al., 2005). While this approach works in principle it has certain limitations.
First, this approach requires the availability of full-length high-quality cDNAs, and
although the list of full-length cDNA clones is growing, a clone may not be
available for any given gene. Second, cDNAs do not allow the expression of
alternatively spliced transcripts. Third, expression from vectors carrying cDNA
inserts is dependent on the promoter used to drive the transgene expression.
Most of these promoters are derived from viral or model vertebrate promoters
that do not recapitulate physiological expression of most transgenes. This may
be critical for many genes, because inappropriate expression levels of a
particular protein could be toxic or cause artefactual effects. In particular for cell
cycle-related genes the regulated expression during specific cell cycle phases
that is essential for the gene function cannot be achieved with constitutive
promoters. Thus, the state-of-the-art cDNA-based approaches are not generally
applicable and reliable for studies that require transgenic tissue culture cells.
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Scope of the thesis
A global view of genes and pathways governing the human cell cycle would
advance many research areas and may also deliver novel cancer targets.
Therefore this work aimed on the genome-wide identification and
characterisation of novel genes required for cell cycle progression in human
cells. For this purpose, I developed technologies that enable functional genomic
studies in human tissue cultures. For large-scale loss-of-gene function screens I
developed an RNA interference technology for the rapid and cost-efficient
generation of libraries based on the synthesis of pools of siRNA by RNase III
digestion from long dsRNA, which is referred to as endoribonuclease-prepared
siRNAs or esiRNAs (Chapter 2). I tested a large library of esiRNAs in a proof-of-
concept study that aimed at the identification of genes required for cell division
(Chapter 3). In this pilot study, the developed technology proved to be an efficient
tool for loss-of-function screens and was therefore subsequently used in
combination with several high-content assays for the functional genomic profiling
of the human cell cycle in a genome-wide study (Chapter 4). For transgenesis in
human tissue-culture cells I established a technology based on the use of
bacterial artificial chromosomes (BACs) to enable physiological expression of
transgenes for rescue experiments, protein localisation and interaction studies
(Chapter 5).
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Chapter 2: Development of esiRNA library technology
Genome-wide RNAi studies in mammalian cells require high-quality libraries of
efficient and specific RNAi silencing triggers. In this chapter I describe the
development of a methodology for high-throughput production of
endoribonuclease-prepared siRNA that enables the rapid and cost-efficient
generation of specific and efficient RNAi reagents covering nearly the entire
human genome.
Concept of endoribonuclease-prepared siRNA
A fast and cost-efficient technology to circumvent the problems of chemically
synthesized siRNAs and shRNAs is the preparation of siRNA through digestion
of long dsRNA with endoribonucleases in vitro (Buchholz et al., 2004; Kawasaki
et al., 2003; Myers et al., 2003; Yang et al., 2002; Yang et al., 2004). By using
bacterial RNase III, which can be easily expressed and purified from E. coli, or
recombinant Dicer (both enzymes are also commercially available), long dsRNA
is converted into siRNAs with a length of 18-25 bp in vitro. This process
generates a heterogeneous population of siRNAs able to interact with multiple
sites of the target mRNA, and recapitulates the potent and specific mRNA
knockdown by long dsRNA in worms and flies. The resulting endoribonuclease
prepared siRNAs (or short esiRNAs) have proven to knockdown genes efficiently
in mammalian tissue culture cells (Yang et al., 2002), in the developing (Calegari
et al., 2002; Calegari et al., 2004) and adult mouse (Xuan et al., 2006), and to
inhibit viral replication (Kronke et al., 2004). Although both Dicer and RNase III
can be used to generate esiRNAs, the two enzymes differ in their mode of
dsRNA cleavage. Dicer cleaves dsRNA in a sequential way, and therefore
generates a mixture of predominantly non-overlapping siRNAs (Zhang et al.,
2002). In contrast, E. coli RNase III digests dsRNA in a random fashion, leading
to a more complex mixture of siRNAs (Drider and Condon, 2004). Due to the
simplicity, cost-effectiveness and time-efficiency of the synthesis, esiRNA
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technology appears to be a versatile alternative to chemically synthesized siRNA
for RNAi studies in mammalian cells.
Results and Discussion
Development of a method for esiRNA library synthesis
An important aspect for large-scale RNAi libraries is the qualitative uniformity
between individual reagent samples. Therefore, I developed a robust protocol for
the synthesis of high-quality esiRNAs at large-scale: cDNA fragments that were
tagged with T7 promoter sequence by PCR were in vitro transcribed to produce
dsRNA. By limited digestion with RNase III, the long dsRNA was then converted
to siRNAs less than 30 bp in length, and subsequently purified by spin
purification in a single column (Figure 1). This method was established in 96-well
format for the rapid synthesis esiRNAs (>2000 per day) for genome-wide libraries
in a standard-sized academic laboratory.
        Figure 1 Flow chart of esiRNA synthesis. The four steps of esiRNA synthesis are
shown with their approximate duration. A detailed protocol of this procedure is
described in the Materials and Methods section.
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Generation of a clone-based human esiRNA library
For the first large-scale human library cDNA clones were used to generate
templates for in vitro transcription. cDNA clones have the advantage that
universal vector-specific primers can be used to amplify the cDNA insert. On the
other hand the obtained cDNA fragments represent a random portion of the
targeted transcript and does not allow the selection of a specified sequence. A
sequence-verified set of cDNA clones that was assembled from an IMAGE clone
set by the RZPD (German Genome Resource Centre) was used to generate a
library of 12,662 esiRNAs (Appendix, Table 1). The cDNA clones were enriched
for fragments close to the 3’UTR (untranslated region) with a typical size-range
from 700-1200 bp.
Generation of an optimised human esiRNA library
Although many of the esiRNAs generated from cDNA clones proved efficient in
RNAi screening (see chapter 3), I aimed to improve the silencing efficiency and
specificity by using the optimal transcript fragment of each gene for esiRNA
synthesis. I observed that cDNA clones often did not contain the sequence
region of a cDNA with the highest silencing efficiency, when compared to optimal
regions predicted in silico by the DEQOR program (see also Figure 4b)
(Henschel et al., 2004). For an improved genome-wide esiRNA library, the
optimal esiRNA target regions were identified for all protein-coding transcripts of
the human, mouse, rat genome in silico and designed gene-specific primers to
amplify these fragments from cDNA. Using this resource an esiRNA library for
the human genome was generated, which currently contains 16,242 esiRNAs.
Several important aspects of this library for efficient RNAi screening were
analysed, including the silencing effectiveness and the potential for off-target
effects. While the comparison of the optimised esiRNAs with state-of-the-art
designed siRNAs demonstrated a similar silencing efficiency, esiRNAs exhibited
a marked reduction of off-target effects. The human library and the data sets for
the mouse and rat genome offers therefore a highly specific resource for loss-of-
function studies in mammalian cells.
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In silico esiRNA target sequence selection
In collaboration with Bianca Habermann’s group an automated algorithm for
predicting optimised esiRNA sequences of a given transcriptome was developed.
This algorithm used all known transcript isoforms of the genes of a genome and
identified first for each gene the longest common region between all splicing
variants. This sequence was then used to identify the most efficient region for
esiRNA-based gene silencing according to state-of-the-art parameters of siRNA
selection as implemented in the DEQOR program. The predicted esiRNA target
sequence was used for computed primer prediction using the Primer3 program.
This algorithm was used to
construct genome-wide esiRNA
libraries for the genomes of
human, rat and mouse.
Predicted esiRNA target
regions were in silico analysed
for their silencing efficiency
(Figure 2). The majority of the
predicted esiRNAs have more
than 40% high-quality siRNAs
per esiRNA, which reflects
highly efficient silencers for
RNAi. The ENSEMBL and
NCBI datasets for the human
genome are furthermore comparable in their quality. It is noteworthy to mention
that the two rodent genomes have more high-quality esiRNAs as compared to
the both human ones. This can be explained by the fact that for both genomes,
less splice variants are annotated, which resulted in a less restrictive DEQOR-
based target selection, due to a lower amount of common overlapping
sequences.
Figure 2 Statistics of DEQOR-based esiRNA
selection. Predicted esiRNAs of each
transcriptomes were analysed for the
percentage of high-quality siRNAs per
esiRNA. Hs (Homo sapiens); Mm (Mus
musculus); Rn (Rattus norvegicus).
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Generation of the optimised esiRNA library
A set of 19,565 primer pairs designed to amplify optimised regions was used for
esiRNA synthesis for most protein coding human genes. In contrast to C.
elegans and D. melanogaster, where genomic DNA was previously used as PCR
template, the amplification of mammalian DNA sequences encompassing the
predicted sequence required the use of cDNA because of the typically large
intron size and the relatively small exon size in mammals. A normalised cDNA
library generated from mRNAs of 32 human tissues and 34 cell lines was used to
maximize the transcript coverage. The PCR primers were appended with two
different T7 promoter sequences that varied by a single 3’ nucleotide (G/C) to
obtain directionality in the resulting PCR product that is useful e.g. for
sequencing or subsequent cloning.
In total, 17,464 (88%) PCR
products were obtained from which 621
products were excluded because their
size differed from the predicted amplicon
length and 556 products with multiple
PCR fragments (Figure 3). Sequencing
of 133 products with the predicted PCR
product length confirmed in all cases the
amplification of the desired fragment
(data not shown). Interestingly,
sequencing of 35 wrong size PCR
products revealed for 18 (51%) of the
analysed samples the amplification of a
transcript of the desired gene that was
alternatively spliced to the predicted
fragment, while the remaining 17 samples represented unspecific products.
Likewise, sequencing of 37 multiple fragment PCR products identified in 17
(46%) cases in addition to the desired product an alternatively spliced transcript
of the same gene.
Figure 3 Statistics of library
generation.
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Single PCR products with the predicted size were in vitro transcribed and
annealed to generate long dsRNAs that were digested with RNase III to 18-25 bp
short dsRNAs and purified. In total, 16,242 esiRNAs with a yield of at least 20 µg
were generated (Appendix, Table 2) that were normalised and re-arrayed in 384-
well plates for large-scale knockdown studies.
Silencing efficiency of optimised esiRNAs
The in silico comparison of a set of 3,173 optimised esiRNAs with their
corresponding clone-based esiRNAs indicated a marked increase of the
predicted silencing efficiency (Figure 4a). DEQOR selection enhanced the
average percentage of high-quality siRNA/esiRNA from 35% for the clone-based
to 43% for the DEQOR-optimised esiRNAs. To verify this improvement of
knockdown efficiency experimentally 15 predicted efficient esiRNAs were
selected from the optimised library and the corresponding clone-based esiRNAs
was picked from the first library for a comparison of their silencing efficiency. For
that purpose, the mRNA knockdown levels were quantified by quantitative RT-
PCR (qRT-PCR) 36 hours after transfection (Figure 4b).
14 optimised esiRNAs and their corresponding clone-based esiRNAs
caused a reduction in the mRNA level of the targeted transcript. The optimised
esiRNAs yielded an average transcript knockdown of 78.9%, whereas the clone-
based esiRNAs resulted in an average knockdown of 67.9%. 7 (50%) optimised
esiRNAs exhibited a significantly better knockdown efficiency than their
corresponding clone-based esiRNAs. Analyses of the in silico predicted silencing
efficiency of the clone-based esiRNAs indicated a mean lower percentage of
efficient silencers for the esiRNAs that were experimentally found to be less
efficient compared to the seven esiRNAs that were similarly efficient as the
optimised esiRNAs (38.9% vs. 45.8% efficient silencers and 11.9 vs. 14.8% best
silencers). The corresponding esiRNAs showed a similar predicted silencing
efficiency (60.7% vs. 61.6% efficient silencers and 19.5 vs. 19.1% best
silencers). For the two esiRNAs targeting SLC38A2 in both cases a ~ 40fold
increase  in  the  mRNA  level was observed, which may either reflect a biological
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Figure 4 Silencing efficiency of optimised esiRNAs. a, In silico analyses of the silencing
efficiency for 3,173 optimised esiRNAs and their corresponding clone-based esiRNAs.
b , Silencing effficiency of 14 optimised and clone-based esiRNAs measured by
quantitative RT-PCR. c, Silencing efficiency of 96 optimised esiRNAs and chemically
synthesized measured by quantitative RT-PCR. For b and c, HeLa cells were harvested
for RNA extraction 36 hours after transfection. Expression levels were normalised
against a negative control (e)siRNA. Error bars represent s.d., ** or *** in panel b
represent significant or highly significant differences, respectively. d, Scatter plot of the
knockdown levels of esiRNAs and siRNA, which indicates a high degree of correlation
between the knockdown levels of the two RNAi reagents.
a b
c
d
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effect upon RNAi or a qRT-PCR artifact, which were therefore excluded from
further analyses.
Next, the silencing efficiency of optimised esiRNAs and chemically
synthesized siRNAs, which are currently the standard RNAi reagents for
transient knockdown experiments, was compared. For that purpose, 96 esiRNAs
targeting 49 genes (typically 2 esiRNAs per gene) were synthesized and an
equal number of corresponding siRNAs was obtained from a commercial
supplier. The analysis of knockdown levels 36 hour after transfection by qRT-
PCR (Figure 4c) revealed overall a similar silencing efficiency for esiRNAs and
siRNAs. 76% of the esiRNAs and 71% of the siRNAs exhibited a knockdown
efficiency >70%. 5 esiRNAs and 6 siRNAs repeatedly did not cause any
reduction in the level of their targeted transcripts. Interestingly, the mean
knockdown efficiency of the two tested constructs per each transcript showed a
highly significant correlation between the siRNAs and esiRNAs (Figure 4d, R2 =
0.83, p-value = 7.7e-19, t-test). Similar results were obtained with diced siRNAs
that were generated from the same templates used for esiRNA synthesis (data
not shown).
Silencing specificity of optimised esiRNAs
Recently, several authors suggested that pooling of siRNAs would enhance
specificity by diluting out off-target effects (Dorsett and Tuschl, 2004; Jackson et
al., 2003). Therefore one could assume that high-complexity pools of siRNAs
inherent to the esiRNA approach may produce less off-target activity than single
siRNAs. To test this hypothesis, transcript regulation by 3 siRNAs and 3 esiRNAs
targeting each of the two transcripts MAPK14 and KIAA1387 (SMEK2) was
profiled. Gene expression signatures obtained after transfection of esiRNAs and
siRNAs into either HeLa cells or HCT116 cells were analysed by microarray
profiling at 12 and 24 hours post-transfection. In total, 5-7 independent
experiments were analysed for each interfering RNA (Figure 5a). There was a
significant difference in the number of transcripts consistently regulated by
siRNAs and esiRNAs (Figure 5b). siRNA signatures showed consistent down-
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regulation of multiple transcripts (median = 26) across cell lines and time points.
In every case, the down-regulated signature was enriched for transcripts with 3’
UTR sequence complementarity to the seed region hexamers of the siRNA guide
strand (Lim et al, 2005; Jackson et al, 2006). In contrast, few transcripts other
than the intended target were downregulated by esiRNAs (median = 2). Neither
siRNAs nor esiRNAs induced the expression of interferon genes. The difference
in the number of transcripts regulated by siRNAs and esiRNAs is significant (p-
value = 0.002, Kolmogorov-Smirnov goodness-of-fit test). Interestingly, the
esiRNAs designed to contain the predicted highest percentage of best silencers
had the smallest signatures (n=0), while the least specific esiRNAs had the
lowest percentage of best silencers (Figure 5c). The correlation between esiRNA
signature size and design confidence is significant (R2 = 0.80, p-value = 0.008, t-
test).
Discussion
The exploitation of RNAi as a functional genomic tool in mammalian tissue
culture cells has revolutionized many fields of biology, in particular cell biology
and cancer research. In combination with various high-throughput assays, e.g.
colorimetric measurements, microscopic imaging and cytometry, large scale
RNAi studies can rapidly identify many novel gene functions in various biological
pathways. For this purpose, several suppliers have made large chemically
synthesized siRNA and vector-expressed shRNA libraries available. As an
alternative to these reagent sets, I generated an open resource that enables the
cost-efficient and rapid synthesis of esiRNAs for almost each human, mouse and
rat gene. The published primer sequences can be used to synthesize single
esiRNAs for small-scale experimentation or for the generation of large-scale
libraries. For this purpose, I have developed a technically simple protocol that
enables low and large-scale esiRNA synthesis in a standard size-lab. To further
facilitate the use of large esiRNA libraries the human PCR products will be
distributed by the non-profit German Genome Resource Centre (RZPD). To date,
an optimised esiRNA library has been completed for most human genes, and for
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 prediction of optimised esiRNA regions of an entire transcriptome will enable the
Figure 5 Expression profiling reveals a marked reduction of off-target effects for
esiRNA. a, Three different siRNA duplexes (siRNA-1 = MAPK14_542, siRNA-2 =
MAPK_569, siRNA-3 = MAPK14_793) and three esiRNAs targeted to the MAPK14
mRNA were transfected into HeLa and HCT116 cells. Changes in transcript regulation
were analysed by microarray profiling and are shown in the heatmap representing the
transcript regulated (x-axis) in 5-7 experiments for each tested silencing trigger (y-axis).
The gold boxes indicate the consensus signatures of down-regulated transcripts for the
MAPK14 siRNAs. The arrow indicates the location of the target transcript MAPK14. b,
Quantitative comparison of off-target effect for the 6 siRNAs and 6 esiRNAs analysed in
this study. c, The number of off-transcripts plotted versus the predicted number of best
silencers for each esiRNA.
a
b c
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the mouse and the rat genome similar libraries will be generated in the near
future.
The approach used for the generation of the optimised human esiRNA
enabled substantial improvements compared to the first clone-based library. As a
key feature, the identification of common sequences for multiple transcripts of the
same gene and the implementation of siRNA design criteria for the synthesis of
optimised esiRNAs increased the efficiency of gene silencing. In addition, the use
of a well-defined size range of the PCR products allowed the streamlining of long
dsRNA synthesis and digestion procedures, thereby reducing the number of
dropouts during esiRNA synthesis and doubling the yield of esiRNA. The use of
normalised cDNA libraries as starting material for high-throughput generation of
PCR products for the synthesis of long dsRNA was technically sound, because
already 82% of the expected products were obtained with one primer pair for
each transcript.
Previous dsRNA libraries for D. melanogaster and C. elegans used
genomic DNA for the amplification of gene-specific fragments (Flockhart et al.,
2006; Kamath and Ahringer, 2003), which is applicable in these organisms due to
the relatively small intron size. In mammalian cells, genomic DNA could have
been used in principle, if the sequence region had been restricted to large coding
exons or the 3’ untranslated region of a gene that is typically not disrupted by
introns. However, the use of genomic DNA would have greatly reduced the
flexibility for the selection of the target sequence. In addition, the use of cDNA
avoided the amplification of pseudogenes that exist for many human genes but
are typically not expressed. In fact, all esiRNAs present in the reported library
must target an existing polyadenylated transcript, because their synthesis from
cDNA relied on the presence of such a transcript in human cells. In contrast to
siRNA and shRNA libraries that are solely based on transcript sequences in
databases, of which many are only in silico predicted and not experimentally
verified, the presence of all transcripts targeted by the esiRNAs in the library has
been demonstrated. In this context, some of the primer pairs that did not produce
a PCR fragment may reflect errors in gene predictions rather than PCR failure.
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Likewise, for ~50% of the analysed problematic PCR products (i.e. multiple
products and products with wrong size) the correct gene identity could be
verified. In these cases a previously unknown splice variants was identified as
the cause for unexpected fragments. To achieve full-genome coverage of the
human library, specific cDNA clones containing the target sequence as template
could be used to generate the missing PCR products. For the amplicons that
cannot be obtained by this approach an alternative primer pair should be tested.
A set of 96 optimised esiRNAs showed a comparable silencing efficiency
to a corresponding set of chemically synthesized siRNA that were designed with
state-of-the-art prediction algorithms. This finding indicates that optimised
esiRNAs have essentially a similar silencing efficacy as predicted efficient
siRNAs, which debilitates previous concerns that complex siRNA mixtures may
exhibit an overall worse silencing performance than single siRNAs (Echeverri
and Perrimon, 2006). Interestingly, there was a highly significant correlation
between the knockdown levels of corresponding siRNAs and esiRNAs. This
finding suggests that the maximum knockdown effect that can be achieved with a
predicted efficient silencing trigger is overall transcript-dependent.
When comparing the global gene expression signatures of 6 esiRNAs with
6 siRNAs, a marked reduction of off-target gene silencing was observed. This
finding confirms a previous prediction that pooling of siRNAs might reduce off-
target effects. The rationale behind that assumption is the very low concentration
of individual siRNAs in a heterogeneous mixture, e.g. ~ 20 pM when using 10 nM
esiRNA derived from a 500 nt fragment. Because each single siRNA in a pool
would have different off-targets while having the same on-target if highly similar
mRNA sequences or repetitive sequences are avoided, the use of a large pool of
siRNAs as inherent to esiRNA should dilute out off-target effects. Also, the
natural RNAi pathway is triggered by long dsRNA that is subsequently cleaved
by Dicer to produce a complex mixture of siRNAs targeting an mRNA. esiRNAs
are designed to mimic this by producing a highly complex mixture of siRNAs with
an enhanced proportion of efficacious duplexes. Interestingly, the predicted best
esiRNAs exhibited no off-target effects, indicating that the in silico prediction of
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the esiRNAs quality can be used as a measure for the reliability of the RNAi
specificity. Because the human esiRNA library is based on in silico predictions to
generate the best esiRNA for each gene one can assume that the number of off-
target effects in a study using this library would be relatively low.
Conclusion
I established a rapid and cost-efficient technology for the generation of large
esiRNA libraries. Through the use of state-of-the-art siRNA design criteria for the
selection of esiRNA sequences a silencing efficiency similar to the best predicted
chemically synthesized siRNAs was achieved. I demonstrated that the high-
complexity pooling inherent to esiRNA greatly reduced the number of off-target
effects, thereby improving the specificity of RNAi phenotypes in loss-of-function
studies. Overall, these findings indicate that the use of esiRNA in large-scale
studies avoids most off-target effects that plague siRNA and shRNA-based
screens.
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Materials and Methods
Reagents for esiRNA synthesis
Agarose, electrophoresis grade (Invitrogen)
BIOTAQ Red DNA polymerase (Bioline)
cDNA clones or cDNA preparations
Deep-well plates (1.1 ml) (Nerbe)
dNTP mix (10 mM) (Bioline)
dsRNA digestion buffer (20 mM Tris-HCl, 0.5 mM EDTA, 5 mM MgCl2, 1 mM
DTT, 140 mM NaCl, 2.7 mM KCl, 5% [v/v] glycerol, pH 7.9)
Elution buffer, (20 mM Tris, 1 mM EDTA, 520 mM NaCl, pH 8.0)
70% (v/v) ethanol, cold
Equilibration buffer, (20 mM Tris, 1 mM EDTA, 300 mM NaCl, pH 8.0)
esiRNA loading dye (3 mg/ml Orange G (Sigma-Aldrich), 5% [w/v] Ficoll (Sigma-
Aldrich))
GST-RNase III
Isopropanol
Marker DNA, for example 25-bp DNA ladder, HyperLadder V (Bioline)
MEGAscript™ in vitro transcription kit (Ambion)
MgCl2 (50 mM) (Bioline)
10x NH4 reaction buffer (160 mM (NH4)2SO4,670 mM TrisHCl, pH 8.8, 0.1% [v/v]
Tween20) (Nerbe)
Q Sepharose FastFlow (Amersham Biosciences)
Silicon seals for deep-well plates (Nerbe)
Wash buffer, (20 mM Tris, 1 mM EDTA, 400 mM NaCl, pH 8.0)
96-well filter plates UNIFIL 98-800U (Whatman)
96-well PCR plates (Nerbe)
33
Generation of the template for in vitro transcription by PCR
The templates for in vitro transcription were generated from cDNA clones or
directly from cDNA using vector- or target-specific primers. For cDNA clones
universal vector-specific primers appended with T7 promoter sequences or
primers binding 5’ to an internal T7 promoter site in the vector backbone were
used to amplify the insert (Appendix, Table 3).
The design of target-specific primers was performed as follows: The cDNA
sequences of all known protein-coding genes of the human, mouse and rat
genomes from the ENSEMBL (release of December 2004) and NCBI database
(release of April 2006) were downloaded. To exclude gene prediction artifacts
and non-protein-coding genes, human ENSEMBL genes with no homologue in
mouse were removed from the dataset and only sequences with more than 350
base pairs (bp) were considered for esiRNA production. Splice variants of genes
were identified based on the gene identifier provided by NCBI and ENSEMBL,
respectively. Longest common regions among splice variants were identified with
a modified version of suffix arrays (Manber & Myers, SIAM Comp.J. 1993). The
resulting sequences of multiple isoforms, as well as full-length transcript
sequences of genes with a single isoform were submitted to a stand-alone
version of DEQOR (Henschel, et al., NAR 2004). High-quality esiRNA regions of
400bp - 600 bp were selected based on the following criteria: 1) the region
selected was within 1500 bp of the CDS upstream of the 3’UTR and within
maximally 500 bp of the 3’UTR; 2) the region selected did not have more than
5% predicted off-targets; 3) the region selected had the highest percentage of
high-quality siRNAs according to their DEQOR score (score < = 5). The selected
regions were submitted to a stand-alone version of Primer3 (Rozen & Skaletsky,
Methods Mol Biol 2000) with default settings and a product size range from 400
bp - 600 bp. Regions that did not result in high-quality primers within this region
were step-wise reduced to a minimum of 220 bp. Primer fragments with less than
220 bp were not considered for further analysis. For statistics on high-quality
siRNAs per esiRNA and off-targets, only the sequence fragments resulting from
primer selection were considered.
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Target-specific primers were appended 5’ with the partial T7 promoter sequence
tags TCACTATAGGGAGAG for the forward primers or TCACTATAGGGAGAC
for the reverse primer. All primers were synthesized by MWG Biotech.
The reaction for amplification was set up for 25 µl volumes as follows:
10 X NH4 reaction buffer 2.5 µl
MgCl2 (50mM) 0.8 µl
dNTP mix (10 mM) 2 µl
T7 Forward primer (10 µM) 1 µl
T7 Reverse primer (10 µM) 1 µl
template DNA (100 ng/µl cDNA) 0.7 µl
BIOTAQ Red polymerase (1 u/µl) 1 µl
Water 16 µl
Amplification was performed with a touch up-PCR as follows:
Cycle Denaturation Annealing Extension
1 2 min at 94°C 30 sec at 60°C 30 sec at 72°C
2-7 30 sec at 94°C 30 sec at 60°C 30 sec at 72°C
8-13 30 sec at 94°C 30 sec at 62°C 30 sec at 72°C
13-33 30 sec at 94°C 30 sec at 65°C 30 sec at 72°C
34 30 sec at 94°C 30 sec at 65°C 5 min at 72°C
The full-length T7 promoter sequence was appended by a second PCR that was
set up for 50 µl volumes as follows:
10 X NH4 reaction buffer 5 µl
MgCl2 (50mM) 2 µl
DNTP mix (10 mM) 4 µl
T7 Forward primer (10 µM) 1 µl
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T7 Reverse primer (10 µM) 1 µl
Amplification product of the first PCR 2 µl
BIOTAQ Red polymerase (1 u/µl) 2 µl
Water 33 µl
Amplification was performed with a touch up-PCR as follows:
Cycle Denaturation Annealing Extension
1 2 min at 94°C 30 sec at 60°C 30 sec at 72°C
2-41 30 sec at 94°C 30 sec at 60°C 30 sec at 72°C
42 30 sec at 94°C 30 sec at 60°C 5 min at 72°C
Annealing temperatures and extension times applies to target-specific primers.
The parameters for the vector-specific primers can be found in Table 3 of the
appendix.
3 µl PCR product were analysed on a 1.5% (w/v) agarose gel with an appropriate
marker.
Generation of long dsRNA by in vitro transcription
For in vitro transcription components from the MEGAscript kit (Ambion) were
used. The reaction in10 µl volume was set up as follows:
10 X T7 reaction buffer 1 µl
UTP (75 mM) 1 µl
ATP (75 mM) 1 µl
GTP (75 mM) 1 µl
CTP (75 mM) 1 µl
PCR product 4 µl
T7 enzyme mix 1 µl
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In vitro transcription and annealing of the two resulting single-stranded RNAs to
generate a long dsRNA was performed in a thermal cycler as follows:
In vitro transcription 4-12 h at 37°C
Denaturation 3 min at 90°C
Ramp to 70°C with 0.1°C/sec
3 min at 70°C
Ramp to 50°C with 0.1°C/sec
3 min at 50°C
Annealing Ramp to 25°C with 0.1°C/sec
Digestion of long dsRNA
The digestion reaction was set up as follows:
10 µl of in vitro transcription product were mixed with 90 µl of dsRNA digestion
buffer, containing 5 µg GST-RNase III, and were agitated vigorously.
The digestion reaction was performed as follows:
The reaction was incubated under agitation for 4 hours at 20-25°C, the
temperature was then shifted to 37°C for a further two hours.
3 µl of digestion product were mixed with 3 µl of esiRNA loading dye and
analysed on a 4% (w/v) agarose gel against an appropriate marker. The
digestion product smear was typically shorter than 30 bp, while most of the
smear should range between 18-25 bp.
esiRNA purification
200 µl of Q-Sepharose (slurry) was added to a Whatman 96-well filter plate. The
filter plate was put on an empty 1.1-ml deep-well plate. 500 µl of equilibration
buffer were added to each well of the filter plate, which was then centrifuged at
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1000 g for 1 min. The flow-through was discarded and another 500 µl of
equilibration buffer were added, followed by centrifugation at 1000 g for 1 min
and discarding of the flow-through. Each well of a filter plate was then loaded
with one digested dsRNA and incubated for 5 min at room temperature and
centrifuged at 1000 g for 1 min. After discarding the flow-through 500 µl of wash
buffer were added, and the filter plate was centrifuged at 1000 g for 1 min. After
discarding the flow-through 270 µl of elution buffer were added, and the flow-
through was collected in a new deep-well plate after centrifugation at 1000 g for 1
min. This elution step was repeated with another 270 µl of elution buffer. esiRNA
was precipitated by mixing the eluted solution with 400 µl of isopropanol, stored
at -20°C for at least one hour, and pelleted by centrifugation at 4,400 g for 60 min
at 4°C. The supernatant was discarded, and the pellet was washed twice with
500 µl of cold 70% (v/v) ethanol. The esiRNA pellet was dried at 37°C for 2 hours
and dissolved in 100 µl of water.
3 µl of purified esiRNA were mixed with 3 µl esiRNA loading dye and
checked on a 4% (w/v) agarose gel with an appropriate marker. The esiRNA
concentration was quantified by measuring OD260. The purified esiRNAs were
normalised and aliquoted at 100 ng/µl.
siRNA for qRT-PCR and microarray experiments
The 96 siRNAs for the analysis of silencing efficiency were obtained from
Ambion. All siRNAs for expression profiling were synthesized by Sigma-Proligo
(Appendix, Table 4).
Transfection for qRT-PCR and microarray experiments
250 nM siRNA or esiRNA (Appendix, Table 5) in 15 µl OptiMEM (Invitrogen)
were added to a mixture of 0.4 µl Oligofectamine (Invitrogen) and 4.6 µl
OptiMEM in a 96 well tissue culture plate (Nunc). After 20 minutes of incubation
at room temperature 9000 HeLa cells in 120 µl medium (DMEM, 11.5% FBS, 2
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mM L-glutamine, 100 U/ml penicillin and 100 µg/ml streptomycin; Invitrogen)
were seeded onto the transfection mix using a WellMate dispensing system
(Matrix).
For microarray analyses, cells were transfected in 6-well plates using
Oligofectamine (HeLa) or Lipofectamine2000 (HCT116) and 10nM siRNA or
esiRNA (Appendix, Table 5).
Quantitative RT-PCR (qRT-PCR)
HeLa cells transfected in 96-well plates were lysed 36 hours after transfection.
Total RNA was extracted using 96-well plate Invisorb kits (Invitek). cDNA was
synthesized with HighCapacity cDNA reagent (ABI). Real-time qRT-PCR was
performed using SybrGreen qPCR mix (Quantance) (see Appendix, Table 6 for
primer sequences) on an ABI 7900HT machine. All samples from one transfected
plate were measured on one plate. Per plate, duplicates (for the esiRNA/siRNA
comparison) or triplicates (for the optimised/clone-based esiRNA comparison)
were performed for every well/cDNA, for both the target gene and for 18S rRNA.
Relative remaining mRNA was calculated for target vs. 18S rRNA levels,
comparing samples vs. two plate-specific controls (negative siRNA control or an
esiRNA targeting renilla luciferase). Quality control was performed by evaluation
of melting curves, individual failed data-points were excluded.
Microarray analysis
RNA from siRNA-transfected cells or esiRNA-transfected cells was hybridized
against RNA from mock-transfected cells (treated with transfection reagent in the
absence of RNA duplex). Total RNA was purified by Qiagen RNeasy kit, and
processed as described previously (Hughes et al., 2001) for hybridization to
microarrays containing oligonucleotides corresponding to approximately 21,000
human genes.  Ratio hybridizations were performed with fluorescent label
reversal to eliminate dye bias.  Error models have been described previously
(Hughes et al., 2001). Data shown are signature genes that display a difference
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in expression level (p<0.01) relative to mock-transfected cells.  No cuts were
placed on fold change in expression.  Blue indicates transcripts downregulated in
transfected cells, pink indicates transcripts up-regulated in transfected cells.
Black indicates no change in expression. Data were analysed using Rosetta
ResolverTM or MatLab software.
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Chapter 3: Pilot screen in human tissue culture cells
In the previous chapter the development of esiRNA library technology was
described. In this chapter I describe a pilot screen with a large fraction of the first
clone-based esiRNA library to test the performance of esiRNA in large-scale
functional studies.
Results and Discussion
High-throughput screening
In this pilot study, I screened for genes that are required for cell division in human
HeLa cells. I assumed that the knockdown of genes essential for cell division
would lead to a mitotic arrest
as previously demonstrated
by many other groups.
Because this would cause a
reduction in cell proliferation
and viability, a colorimetric
viability assay was used as a
rapid initial screen. This
homogeneous assay was
based on the cleavage of the
tetrazolium salt WST-1 by
mitochondrial
dehydrogenases, and was
therefore used to determine
the metabolic activity of
viable cells as an indicator
for proliferation and viability
defects (Figure 6).
Figure 6 Screening strategy. Strategy of a
screen for genes essential for cell division.
Important steps are depicted in italic.
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The primary screen identified 275 esiRNAs that had an effect on cell growth or
viability of which 133 were highly significant with a threshold of three standard
deviations (Appendix, Table 7). Using the same criterion a genome-wide screen
on cellular growth and viability in fly cell lines reported 2.3% of the analysed
genes to be essential (Boutros et al., 2004). Thus, the percentage of essential
genes detected by the screen in HeLa cells is almost identical to that reported
recently for Drosophila tissue culture cells. Further analysis revealed that 71.8%
of the human orthologues of the essential fly genes present in the esiRNA library
were also found to be essential for cell viability in HeLa cells (Appendix, Table 8).
This likely reflects conservation of fundamental biological processes between fly
and human cells, and indicates that the esiRNA screen in HeLa cells was
similarly efficient to the screen in Drosophila cells.
To identify cell division phenotypes among the hits of the primary screen a
video microscopy assay was performed for the 275 candidate genes to classify
observable phenotypes (Figure 6). The video microscopy assay allowed detailed
spatial and temporal description of mitosis and cytokinesis that was used to
identify cell division phenotypes for 37 genes. The remaining 238 knockdowns
displayed a variety of additional phenotypes (data not shown).
Analysis of cell division defect phenotypes
The 37 genes that caused cell division defects upon knockdown were analysed
for functional annotation in the unification database HARVESTER (Liebel et al.,
2004). For nine genes no functional annotation was found. Thus, a function in
cell division could be assigned to nine previously uncharacterised genes. For the
remaining 28 genes functional annotations were found, of which seven are based
on electronic annotation and have not been experimentally verified. Interestingly,
24 genes had previously only been associated with other functions than cell
division. This may reflect that the perturbation of various cellular processes that
have previously not been associated with cell division may e.g. activate
checkpoints or cause spindle defects leading to the observed phenotypes.
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Based on the time-lapse microscopic phenotypes, the 37 cell division
phenotypes were grouped into the following three categories (Table 1): mitotic
arrest (Figure 7b, d), aberrant cytokinesis (Figure 7g, h) and cell death upon
entry into mitosis (Figure 7i). Nineteen esiRNAs that caused a mitotic arrest
phenotype led to cell death after prolonged latency in mitosis. These genes most
likely stop the cells from progressing further through mitosis and ultimately
induce cell death. Six gene knockdowns caused the cells to die quickly upon
entry into mitosis. Therefore, these genes may be directly linked to cell death
when cells enter mitosis. Twelve esiRNAs led to an aberrant cytokinesis
phenotype, of which 10 also displayed a mitotic arrest phenotype. These
phenotypes could further be divided into two classes. The knockdown of ITPR1,
MFAP1, AD024, GALNT5, CKLFSF4, and KIAA0056 resulted in a cell cleavage
defect that led to bi-nucleated cells after mitosis (Figure 7g). A very different
cytokinesis phenotype was observed for SNRPA1, SNRPB, DHX8, SNW1,
FLJ10290, and importin beta (KPNB1). For these gene knockdowns, some cells
rounded up (as normally observed for cells entering mitosis) but exit after some
time without any sign of cell division. These cells then contained only one
nucleus with a disorganised appearance, e.g. substructures such as the nucleoli
were not visible (Figure 7h). For DHX8 and SNW1 a cytokinesis defect was
observed that led to the formation of small cell fragments devoid of Chromatin
(cytoplast), which collapsed shortly after the cells had divided.
The cell division phenotypes were further examined by analysing the
spindle morphology after gene knockdown. Severe spindle defects were
observed for 23 genes displaying different aberrations. The RNAi phenotype of
20 genes exhibited spindles with two or more microtubule foci and a reduced
number of microtubule connections between the foci and the chromosomes
(Figure 8d-h), which may indicate a defect in microtubule assembly and/or the
centrosome cycle. For seven genes that displayed a mitotic arrest no obvious
spindle defects were observed indicating another primary defect for the mitotic
arrest (e.g. a chromosome segregation defects).
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Table 1 37 genes essential for cell division in human cells
gene functional annotation mitotic arrest cytokinesis death1 spindle
CDC16 APC/C subunit x Abnormal
CDC27 APC/C subunit x Abnormal
CENPE Motor protein x Normal
KIF11 Motor protein x Abnormal
KIAA0056 Condensin subunit x x Abnormal
AD024 Kinetochore protein x x Abnormal
RRM2 Ribonucleotide reductase x Abnormal
GALNT5 Glycosyl transferase x x Normal
CKLFSF4 Cytokine x Normal
HRI Protein kinase x Abnormal
ITPR1 Receptor protein x Normal
PSCD3 Receptor protein x Normal
CASP8AP2 Apoptosis factor x Normal
DDX5 Splicing factor x Abnormal
DHX8 Splicing factor x x Abnormal
LSM6 Splicing factor x Abnormal
SART1 Splicing factor x Abnormal
SNRPA1 Splicing factor x x Abnormal
SNRPB Splicing factor x x Abnormal
SNW1 Splicing factor x x Abnormal
MFAP1 Microfibril component x x Abnormal
ZDHHC5 Transcription factor x Normal
DDX48 Translation factor x Abnormal
EIF3S3 Translation factor x Unclear
EIF3S10 Translation factor x Unclear
CLDN16 Structural protein x Abnormal
KPNB1 Importin x x Abnormal
VCP (p97) Vesicular transport protein x Abnormal
AP1S1 Vesicular transport protein x Normal
ATP6V1D Vacuolar ATPase x Normal
DKFZP564M082 Unknown x Abnormal
FLJ10290 Unknown x x Unclear
FLJ20311 Unknown x Abnormal
FLJ30851 Unknown x Abnormal
MGC3248 Unknown x Normal
FLJ38663 Unknown x Abnormal
MGC2603 Unknown x Normal
1 cell death upon entry into mitosis
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Figure 7 Cell division phenotypes visualised by video microscopy.
a-i, HeLa cells were transfected with esiRNAs targeting SNW1 (b),
FLJ30851 (d), KIAA1387 (f), and firefly luciferase as negative
control (a, c, e), GALNT5 (g), SNRPA1 (h) and RRM2 (i).
Microscopic images were taken after 48 hours (a, b, c, d) or 72
hours (e and f). The arrows indicate cells in metaphase for the
negative control (e), the knockdown phenotype (f), cells with
cytokinesis defects (g and h). The small arrows in (g) indicate the
two nuclei in the cell. Numbers indicate minutes after the start of
the time-lapse sequence. Bars are 40 µm.
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Figure 8 Spindle and cytokinesis defects observed for RNAi
phenotypes. a-l, HeLa cells were transfected with esiRNA targeting
firefly luciferase as negative control (a, j), KIF11 (b), DDX48 (c),
SNW1 (d, l), DHX8 (e, k), MFAP1 (f), DKFZp564M082 (g),
FLJ30851 (h), importin b (i) and imaged by 3D deconvolution
microscopy 48 hours after transfection for tubulin (red) and DNA
(blue). Bars are 5 µm. The arrows in (j) and (k) indicate the position
of the cleavage furrow. The arrow in (l) points to the collapsed
cytoplast.
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The knockdown of KIF11 (Figure 8b) and DDX48  (Figure 8c) resulted in
monopolar spindles. KIF11 is a kinesin-like motor protein that is required for
centrosome separation and therefore the establishment of a bipolar spindle
(Blangy et al., 1995). The depletion of KIF11 results in the formation of a
monopolar spindle and consequently a mitotic arrest through the activation of the
spindle checkpoint (Harborth et al., 2001). DDX48 is a nuclear matrix protein and
a putative RNA helicase that is highly similar to the translation initiation factors
eIF4AI and eIF4AII (Holzmann et al., 2000). Because of the identical phenotype
of the KIF11 knockdown and the DDX48 knockdown this data suggests that
DDX48 is required for centrosome duplication and/or separation. For importin
beta (KPNB1) many rounded-up cells with apparently uncondensed chromatin
and an interphase level of microtubule nucleation were observed (Figure 8i).
Thus, although the cell cortex displays the characteristics of a mitotic cell, the
presence of uncondensed chromatin rather suggests that these cells are in
interphase. Since importin beta is a key component for Ran-dependent nuclear
protein import (Weis, 2003), the RNAi phenotype suggests that importin beta
may be required for the import of proteins that trigger the progression of the
interphase nucleus into the mitotic nucleus.
Surprisingly, many genes that displayed cell division phenotypes with
severe spindle defects are known components of the splicing machinery, such as
SNRPA1, SNRPB, SNW1, DHX8, DDX5, LSM6 and SART1. In principle, there
are two possible explanations for this phenomenon: The simplest explanation
would be that the cell division defect is an indirect consequence of defects in pre-
mRNA splicing. In this scenario, the depletion of splicing factors leads to
impaired pre-mRNA processing for genes essential for cell division processes,
which in turn results in the depletion of the corresponding protein(s). This has
indeed been shown for the temperature-sensitive yeast splicing factors PRP16,
PRP19 and Cef1p, which impair alpha-tubulin synthesis thereby preventing
spindle assembly (Biggins et al., 2001; Burns et al., 2002). According to this
scenario, the knockdown of the splicing factors precedes the depletion of gene(s)
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essential for cell division, which then results in impaired mitosis as a secondary
effect.
An alternative explanation would be that some splicing factors are directly
linked to cell division. Several points indicate that this may indeed be the case:
First, an indirect effect of splicing factors on cell division would imply that the
turnover rate of these proteins and the subsequent depletion of the mitosis-
specific gene(s) would have to be fast. However, it has recently been reported
that most splicing factors have a low turnover rate (Prasanth et al., 2003).
Because all spliceosome RNAi phenotypes became visible within 36 to 48 hours
after transfection (like all other direct phenotypes I observed), it is difficult to
imagine that the subsequent depletion of the mitosis-specific gene(s) would be
fast enough and sufficient to explain the cell division phenotypes. Second, in the
yeast experiments a marked reduction of a-tubulin levels was noted upon
inactivation of spliceosome subunits (Biggins et al., 2001; Burns et al., 2002). In
contrast, the tubulin stainings did not show a detectable change in α-tubulin
levels (see Figure 8). Third, nuclear run-on experiments of several splicing factor
knockdowns showed that general transcription, and therefore splicing, is not
affected (data not shown). Forth, TPX2, a protein required for chromosome-
induced microtubule assembly during spindle formation (Gruss et al., 2002) has
recently been shown to co-purify with spliceosome components (Makarov et al.,
2002). Interestingly, the spindle defect observed upon TPX2 depletion by RNAi
(Garrett et al., 2002) resembles the phenotype observed here with some splicing
factors, therefore supporting the idea of a direct link between splicing factors and
cell division. In this context it is worth mentioning that MFAP1, an extracellular
matrix component of the elastin-associated microfibrils displayed a cell division
phenotype similar to that observed with the splicing factors in this study and was
also found to be a component of the spliceosome by mass spectrometry
(Makarov et al., 2002). Future studies will be required to determine if the
observed cell division defects are indirect (through impaired splicing) or direct
through the interaction of splicing factors with the spindle assembly machinery.
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Another unexpected finding of this study was the identification of a gene
whose knockdown increases growth-rate. Very few genes have thus far been
described where a loss-of-function leads to an increase in cell growth. One
example being p27kip1, which opposes mitotic stimuli and thus has a negative
regulatory role on cell proliferation (Sherr and Roberts, 1995). p27Kip1 has been
shown to play an important role in differentiation, development, and cancer
(Coqueret, 2003). Consistent with its function, p27kip1 was also identified in this
screen to result in significantly increased growth-rate. For another gene in this
class (KIAA1387) I observed a remarkable cell division phenotype. The knock
down of this gene of unknown function, for which only several predictions of the
coding sequence exist, led to a unique phenotype characterised by the absence
of rounding-up during mitosis (Figure 7f). The partial detachment of the cell
during mitosis is a general feature of many epithelial cells, although the reason
for this morphological change is not completely clear. The analysis of the time-
lapse movie revealed continuous cellular attachment during mitosis for some
cells (Figure 7f). In addition, these cells also progressed significantly faster
through mitosis. The average time in mitosis for control cells was measured at
36±8 minutes, whereas cells transfected with esiRNA targeting KIAA1387 had an
average time of 26±7 minutes. Because the complete sequence of human
KIAA1387 was not known, this gene was cloned and sequenced from cDNA, and
two splice-variants were identified in HeLa cells. To determine the cellular
localisation of KIAA1387 N- and C-terminal GFP fusion constructs were
generated that revealed that it is a nuclear protein (data not shown). Sequence
analysis showed that the KIAA1387 sequence contains a PH-like domain, a
DUF625 (domain of unknown function) and ARM (armadillo) repeat domains.
Evaluation of screening efficiency and specificity
Crucial parameters for RNAi screens are the efficiency and specificity with which
each gene is silenced. In order to test the efficiency of this screen I performed
two types of analyses. First, two large multi-protein complexes were chosen, the
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20S (core) proteasome and the ribosome, and identified which of their subunit
genes were present among the 5305 esiRNA target library after the cell viability
screen. As both these complexes are essential, the effective knockdown of each
of these proteins should score in the primary cell viability assay and thereby
measure of the efficiency of this screen. EsiRNAs targeting nine out of nine
proteasome core subunits (Figure 9) and 23 out of 26 ribosomal proteins (Figure
10a) scored in the cell viability assay. Importantly, the three remaining ribosomal
genes either were not expressed in HeLa cells (the Y-specific isologue RPS4Y)
or are retroposons, dispensable for ribosomal structure and function (Figure
10b). Thus all genes from these protein complexes essential for growth and
viability were detected. Second, I compared published data on RNAi-mediated
cell division phenotypes in tissue culture cells with this data set. I found 26
publications reporting 32 cell division defects upon mRNA knockdown. Of these,
11 genes were present in the esiRNA library, of which 9 were reported to result in
reduced cell viability (Appendix, Table 9). Six of these nine genes (67%) scored
in the cell viability assay.
Figure 9 Efficiency of the esiRNA screen. Effect on cell viability of esiRNAs
targeting subunits of the 20 S proteasome.Cells were assayed 72 hours
after transfection. Cell viability was normalised against control esiRNA
transfected cells (esiRNA directed against firefly luciferase). All error bars
represent s.d.
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In order to evaluate the specificity of esiRNA in this screen, I first analysed
the set of ribosomal genes in more detail. The three ribosomal genes that did not
score in the screen share 79-90% DNA sequence similarity to genes that did
score (RPS4X/RPS4Y, RPL12/RPL12-like, RPL10/RPL10-like), suggesting that
esiRNA is highly target-specific. This was further confirmed by quantification of
RPS4X knockdown after transfection of esiRNAs specific for RPS4X and RPS4Y,
which are 82% identical (Figure 10c). Second, I generated an independent
esiRNA for 21 identified essential genes for cell division using a different region
of the gene for esiRNA production, and found that all of them produced the same
Figure 10 Specificity of the esiRNA screen. a, Effect on cell viability of esiRNAs
targeting cytoplasmic ribosomal subunits. b, Effect on cell viability of three
esiRNAs targeting essential ribosomal proteins (RPL10, RPL12 and RPS4X)
and their paralogs (RPL10L, RPL12L and RPS4Y). For (a and b) cells were
assayed 72 hours after transfection. Cell viability was normalised against
control esiRNA transfected cells (esiRNA directed against firefly luciferase). c,
RPS4X mRNA expression after transfection of esiRNAs targeting RPS4X and
RPS4Y). All error bars represent s.d.
a
b c
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phenotype (data not shown), suggesting a high degree of specificity for esiRNAs.
This was not unexpected in the light of the results described in the previous
chapter, which suggest that the pooling of siRNAs inherent to esiRNA reduces
off-target effects.
Conclusion
In summary, this pilot study has uncovered novel human genes associated with
cell division thereby creating starting points to gain novel insights into this
fundamental biological process. This screen also highlights the potential of gene-
by-gene RNAi screens in mammalian cells utilizing esiRNA. The method allows
efficient and specific identification of novel gene functions and is easily
adjustable to different cell-based assays. Overall, esiRNA-based screening
appears to be well suited to deliver novel insights into various aspects of
mammalian cell cycle regulation.
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Materials and Methods
Cell-based RNAi screening
HeLa cells were seeded 16 hours before transfection into 96 well plates with a
density of 1200 cells per well in 100 µl medium (DMEM, 10% FBS, 2 mM L-
glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin). Transfection was
performed in triplicate using 25 ng esiRNA and oligofectamine (Invitrogen). Cell
viability was measured 72 hours after transfection using the WST-1 assay
(Roche Diagnostics) with a DigiScan 400 microplate reader (ASYS) at 450 nm
and 620 nm as reference wavelength. Absorption values were background
subtracted and mean centred for each 96 well plate. In the initial screen I
generally scored all genes for which at least twice a normalised value >1.645 SD
or smaller than <-1.645 SD was obtained. These cut-off values represent 10% of
all outliers assuming normal distribution. For all positive hits I re-synthesized
esiRNA starting from the original cDNA clones, which were re-sequenced and
confirmed by BLAST search against the published sequence of the human
genome.
esiRNAs for the proteasome core subunits and the cytosolic ribosomal
proteins that scored in the cell viability assay were re-arrayed together with the
three ribosomal paralogues that did not score and negative controls on a 96 well
plate. Transfection and WST-1 assay were performed as described above.
Time-lapse microscopic assay
For the secondary screen I re-arrayed the esiRNAs that scored in the first screen
with three negative controls (esiRNA targeting firefly luciferase) per 96 well plate.
I examined all 275 genes by time-lapse bright field microscopy with one frame
per 10 minutes over 48 hours starting 30 hours after transfection. This was done
with an Axiovert 200 microscope (Zeiss), using a 5X objective with an integrated
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automatic stage and incubator using METAMORPH software. The frequency of
cells in mitosis was quantified for all arrest phenotypes by counting on average
200 cells at three different time-points (frame 1, frame 150 and frame 251). For
KIAA1387 and the luciferase control the average time in mitosis was calculated
by counting the frames between entry and exit from mitosis of 40 cells from
frame 250 onward. All movies are provided in the movie set 1 in the appendix.
Immunofluorescence and microscopy
For visualising the morphology of the mitotic spindle HeLa cells transfected and
grown on coverslips were fixed and permeabilized in methanol at -20°C for 8
minutes. Cells were washed with PBS and incubated 10min in PBS containing
0.2% fish skin gelatine (PBS/FSG, Sigma) to prevent non-specific binding of
antibodies. Cells were incubated 20 minutes with a mouse monoclonal antibody
against tubulin (DM1, Sigma) diluted to 1 µg ml-1 in PBS/FSG, washed in PBS,
incubated 20 minutes at 37°C in 1 µg ml-1 (in PBS/FSG) of secondary antibodies
coupled to TexasRed and washed in PBS before mounting in presence of DAPI
(1 µg ml-1) to visualize chromatin. Three dimensional data sets were acquired on
a DeltaVision imaging system (Applied Precision) equipped with a Olympus IX70
microscope, a Coolsnap camera (Roper Scientific) and a 100x 1.4 NA
PlanApochromat objective. Images were computationally deconvolved using the
SoftWork software package (Applied Precision) and shown as two-dimensional
projections.
Quantification of RPS4X expression
HeLa cells were transfected with esiRNA directed against RPS4Y, RPS4X, and
firefly luciferase as negative control. Cells were harvested 48 hours after
transfection. RNA was extracted using the RNeasy Mini Kit (Qiagen) including a
DNase I digest. Using an oligo(dT) primer cDNA was synthesized with
54
SuperScript II reverse transcriptase (Invitrogen). RPS4X mRNA expression was
quantified by qRT-PCR using the Brilliant SYBR Green system and the Mx4000
Multiplex Quantitative PCR system (Stratagene). For RPS4X I used the primers
5’-CCTGGATCTTTTGACGTGGT-3’/5’-TTTCCTCGGGGAAGAGAAAT-3’, and
for the reference gene B2M (GenBank accession number: NM_004048) 5’-
TGACTTTGTCACAGCCCAAG-3’ 5’-AGCAAGCAAGCAGAATTTGG-3’.
Expression levels of RPS4X in cells transfected with RPS4X- and RPS4Y-
specific esiRNA were normalised against the expression level of cells transfected
with esiRNA targeting firefly luciferase. All experiments were done in triplicate.
Comparison with a previous Drosophila screen
Boutros and colleagues reported 438 (2.3%) of the analysed genes to be
essential in the Drosophila tissue culture cell lines S2R+ and Kc167 (Boutros et al.,
2004). Using the same cut-off value of three standard deviations the pilot screen
yielded 133 (2.5%) essential genes. I performed a detailed comparison between
the fly and the human study: All potential human orthologues of the 438 essential
Drosophila genes were identified by reciprocal best BLASTP between the fly and
human proteomes using a cut-off E-value of 1e-04. I then searched the esiRNA
set of 5305 genes for these orthologues and analysed which of these genes
scored in the cell viability assay in HeLa cells with more than three standard
deviations. This analysis revealed that 71.8% of the orthologues present in the
library were also found to be essential in the HeLa screen.
Cloning of KIAA1387-GFP constructs
PCR fragments containing the coding sequence of KIAA1387 tagged with
PstI/KpnI restriction sites was amplified from cDNA with the primer pair 5'-
A T T C T G C A G A A A T G T C G G A T A C G C G G C G G C G A - 3 ' /  5 ' -
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ATTGGTACCCTGAGCCAAGACGAGGTCTTTTCC-3' using the Expand High
Fidelity PCR system (Roche Diagnostics). The PCR fragments were PstI/KpnI-
digested, and ligated to pEGFP-N2 (Clontech) utilizing the vector’s PstI/KpnI
sites. 12 clones were sequence-verified and subsequently transfected into HeLa
cells using Effectene (Qiagen).
Immunofluorescence and microscopy for KIAA1387 localisation
For localisation of KIAA1387 HeLa cells expressing KIAA1387-GFP grown on
coverslips were fixed and permeabilised 20 minutes in 4% PFA at room
temperature, washed with 0.2% Triton X-100 in PBS, quenched with 50 mM
NH4Cl, washed with 0.2% Triton X-100 in PBS, and blocked 30 minutes with
1.5% BSA. Cells were incubated 30 minutes with 1:500 rhodamine phalloidin
(Molecular Probes) and 1:10000 DAPI in blocking buffer at room temperature,
and washed three times in PBS before mounting. Immunofluorescence images
were acquired with the laser-scanning microscope 510 and processed with
LSM510 software version 3.2 (Carl Zeiss).
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Chapter 4: Genome-wide RNAi profiling of cell cycle
progression in human tissue culture cells
In the previous chapter I demonstrated that esiRNA technology is a sophisticated
tool for the identification of novel cell cycle genes in human tissue culture cells. In
this chapter I describe a genome-wide screen with all generated human esiRNA
resources to obtain a systematic picture of the genes essential for cell cycle
progression in human cells. I used DNA content analysis for the initial detection
of cell cycle defects, which were then further analysed by fluorescent imaging,
cytometry and video microscopy. Using hierarchical clustering I grouped the
identified genes based on their multiparameter signatures into phenotypic
classes as a prelude to in-depth analyses of their specific function.
Results and Discussion
Genome-wide phenotypic analysis of cell cycle defects
Because the transition between G1, S, G2 and M phase is tightly controlled by
checkpoints, which prevent progression through the cell cycle until the accurate
completion of a phase, the downregulation of genes essential for a specific cell
cycle phase by RNAi could lead to a lengthening or an arrest of the affected
phase. The primary assay for the detection of cell cycle defects upon RNAi
knockdown was therefore based on DNA content analysis.
DNA content analysis determines the percentage of cells within a
population in G1, S and G2/M phase. It relies on the specific DNA content of
each phase, i.e. 2n for G1 phase, 2n-4n for S phase and 4n for G2/M. This
methodology allows the detection of both delays and arrests in these phases
because the percentage of each phase of an unsynchronized cell population
reflects the average phase duration. Because cell division defects that result in
binucleated or tetraploid cells have a characteristically increased DNA content
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(8n peak) they can also be detected with this approach. DNA content analysis is
typically performed by flow cytometry of cells stained with a fluorescent DNA
binding dye. Recently, this method has been employed for the analysis of cell
cycle defects in an RNAi analysis of 228 Drosophila kinases and in a large-scale
screen of 11,971 Drosophila genes (Bettencourt-Dias et al., 2004; Bjorklund et
al., 2006).
For high-throughput screening I developed a rapid and robust DNA content
assay for the analysis of adherent mammalian cells. As an alternative to flow
cytometry, the assay is based on laser-scanning cytometry of propidium iodide
(PI)-stained nuclei of adherent cells without the need to bring them into
suspension. The assay accurately reported various RNAi phenotypes of a test
set of known cell cycle regulators, indicating that this approach allows the
identification of cell cycle defects in a large scale screen (data not shown). I
applied this methodology for screening a genome-wide esiRNA library targeting
17,900 protein-coding human genes (Appendix, Table 10), and identified 2149
genes that caused a cell cycle defect when downregulated (Figure 11). In order
to refine and verify the results of the primary screen I first analysed the
expression status of the hit genes in HeLa cells. Assuming that a “true” hit gene
should be expressed in HeLa, this analysis should identify obvious false-
positives. For the 1841 genes that passed this first filter I re-synthesized the
corresponding esiRNAs for the secondary screen. I tested the reproducibility of
the hit phenotypes by repeating DNA content analysis, and was able to
reproduce 75% of the initial phenotypes, yielding in total 1389 candidate genes
involved in cell cycle progression (Appendix, Table 11). From the secondary DNA
content analysis seven parameters were extracted: G1, S, G2/M, 8n DNA
content, cell number, the percentage of dead cells/debris (subG1, i.e. a DNA
content < 2n) and the percentage of cells with 4n-8n DNA providing a measure
for aneuploid cells (Figure 12a,b). I carried out two additional assays to further
characterise  the  cell  cycle  defects  identified.  The  first assay was designed to
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Figure 11 Screening strategy. Flow diagram of the genome-wide screening
strategy for genes essential for cell cycle progression in human cells.
Important steps are shown in italic.
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Figure 12 High-throughput detection of cell cycle parameters. a, PI stained nuclei of cells in a single
well of a 384-well plate were analysed by laser scanning cytometry 72 hours after transfection with
control esiRNA targeting firefly luciferase. b, Fluorescence intensities were plotted in a DNA content
histogram and used for gating of different cell cycle populations. c-h, Scatter plots of a replicate 384-
well plate pair for the percentages of DNA content of G1 phase (c), S phase (d), G2/M phase (e),
aneuploid (f), polyploid (g) and dead cells (h). The r values indicate the average linear correlation
coefficient for replicate plate pairs. i-p, The high reproducibility of DNA content analysis allowed
reliable detection of multiple cell cycle defects, e.g. G1 arrest (i,j), G2/M arrest (k,l), S arrest (m,n)
and accumulation of polyploid cells (o,p) as observed 72 hours after the knockdown of four genes
indicated in the DNA content histograms. Abbreviations: subG1 (debris/dead cells), G1 (G1 phase),
S (S phase), G2/M (G2/M phase), aneu (aneuploid cells), polypl (polyploid cells)
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distinguish between G2 arrest and mitotic arrest phenotypes. This was required
since the primary assay could not discriminate between these two cell cycle
phases because they share the same DNA content. For this purpose the mitotic
index for each hit gene was determined by counting mitotic cells using automated
microscopy and image analysis. The second assay determined cell size as an
indicator of cell growth by high throughput flow cytometry. Reproducibility was
documented by linear regression analysis of all replicate plate pairs, which
yielded a high degree of reproducibility for the determined cell cycle parameters
(Figure 12c-h). Therefore, this screen allowed the accurate detection and
quantification of different types of cell cycle defects (Figure 12i-p). The
reproducibility of the determined cell number, mitotic index and cell size was also
documented by linear regression analysis as for the other six parameters shown.
I determined the following r values (indicated in brackets) for cell number (0.90),
mitotic index (0.78) and cell size (0.66).
To evaluate the rate of false-positives in this study, I used the reproducibility
of an RNAi phenotype with a second independent esiRNA for a sample set of 50
novel genes or known genes with a novel cell cycle function identified in the
screen as a measure of specificity. I found 82% of these esiRNAs producing the
same RNAi phenotype detected in the screen (Appendix, Table 12).
Extrapolating this result to the whole data set, I estimate that the false positive
rate of this screen is below 20%.
Systematic cell cycle analysis by phenotypic profiling
The three assays conducted during the secondary screen produced a nine-
parameter fingerprint for each phenotype. I used these signatures to functionally
group the corresponding genes, assuming that phenotypic profiles should reflect
similar functions during the cell cycle. For this purpose I applied hierarchical
clustering algorithms successfully used previously to analyse large RNAi data
sets (Bjorklund et al., 2006). Based on the obtained gene clusters (Figure 13a)
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and manual inspection I grouped the 1389 genes identified into four phenotypic
classes: G1 arrest, S arrest, G2 arrest, and cell division defects (see Appendix). I
tested the reliability of phenotype grouping by searching the hit list for known cell
cycle regulators, e.g. key regulators of G1/S transition (E2F1, MYC, CCNE1,
TFDP1) and found all of them in the expected cluster (Figure 13a). Quantitative
analyses showed that knockdowns leading to an increased G1 DNA content
represent more than 50% of all detected phenotypes (Figure 13b). This
observation is consistent with the concept that proliferation of somatic
mammalian cells is controlled primarily by regulating the progression through G1
phase and entry into S phase (Massague, 2004). About one third of the G1
phenotypes showed a significant reduction in cell size, suggesting a primary
growth defect.
To annotate the identified genes I searched for functional data in two
databases. I identified 216 genes that have been previously associated with cell
cycle progression, and assigned a novel function in cell cycle progression to 259
previously uncharacterised genes (see Appendix). Furthermore, I identified 914
known genes that had been previously implicated in functions other than cell
cycle. In total, I therefore assigned a novel direct or indirect function in cell cycle
progression to 1173 genes. Further comparative analyses of RNAi phenotypes of
the D. melanogaster homologues identified 51 genes with a highly conserved
function in cell cycle progression (Appendix, Table 13). I grouped the 1389 genes
into 12 functional categories (Appendix, Table 11) that include processes that are
in particular relevant for cell cycle regulation, such as transcriptional regulation,
protein (de)ubiquitination and protein (de)phosphorylation. The latter two
processes each represent recurrent themes of cell cycle regulation by the rapid
removal of proteins through ubiquitin-mediated degradation and protein
(in)activation through the change of the phosphorylation status by kinases and
phosphatases. I detected 99 genes involved in ubiquitin-mediated protein
degradation, of which 55 were previously not implicated in cell cycle regulation.
Likewise, 74 genes involved in protein (de)phosphorylation were detected, of
which 39 are novel for cell cycle progression.
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Figure 13 Phenotypic profiling of cell cycle defects. a, Hierarchical clustering of cell cycle
defects based on their phenotypic signatures. The coloured lines to the left of the heat map
indicate the major clusters and the predominantly represented cell cycle defect class is written in
the same colour with example genes of these clusters shown in italics. Exemplified protein
complexes for which subunits were found in specific clusters are shown with regular font. b,
Classification of 1389 cell cycle defects based on hierarchical clustering and subsequent manual
inspection. c, PCNA has the most similar phenotypic profile to C17orf41, potentially reflecting
functional interaction. d-f, Subunits of the same protein complex display similar signatures, e.g.
for COPI (d), 20S proteasome (e) and 19S proteasome (f). Abbreviations: G1 (G1 phase), S (S
phase), G2M (G2/M phase), ANEU (aneuploidy), POLY (polyploidy), MIT (mitotic index), CSIZE
(cell size), CNUM (cell number), CDEATH (dead cells); APC (anaphase promoting complex),
CCT (chaperonin-containing t-complex polypeptide 1), Ndc80 (Nuf2-Ndc80 complex), CAF
(Chromatin assembly factor 1), COPI (coatomer I complex)
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Analysis of the four phenotypic classes revealed that these clusters indeed
reflect specific processes. For example, the silencing of genes implicated in DNA
replication (e.g. CDC45L, PCNA, DNA polymerases) and dNTP synthesis (e.g.
RRM1, RRM2) caused a delay in S phase. A similar phenotype was observed for
the knockdown of genes coding for histones, histone expression (e.g. SLBP,
NPAT ) and chromatin assembly (e.g. CHAF1A) which reflects the tight
coordination of histone and DNA synthesis necessary for the proper replication of
chromatin (Nelson et al., 2002; Ye et al., 2003). Interestingly, the knockdown of
genes essential for protein biosynthesis (e.g. 51 out of 52 detected cytoplasmic
ribosomal proteins) also led to a delay of S phase progression, which is likely an
indirect effect caused by impaired synthesis of histones during S phase. Because
all known players in chromatin replication and protein biosynthesis among the
annotated candidate genes represent ~ 50% of the phenotypes leading to S
phase arrest, it is plausible to assume similar functions for previously
uncharacterised genes displaying the same phenotype. In this context, the
combination of phenotypic clustering with bioinformatics (domain annotation and
the analyses of homologues) enables the assignment of a putative function to
unknown genes with considerable predictive power. For example, BLAST
analysis of the predicted gene C17ORF41, which resulted in a pronounced S
phase delay revealed weak protein sequence similarity (E=5e-14) to RFC1
(replication factor C 1). RFC1 is essential for the loading of PCNA onto the 3'
ends of primer DNA to form a DNA sliding clamp that keeps DNA polymerase
engaged at the replication fork (Shiomi et al., 2000). Strikingly, PCNA was
identified as the closest phenotypic profile neighbour of C17ORF41 (Figure 13c).
While a weak sequence similarity of C17ORF41 to RFC1 alone would be
insufficient for functional annotation, in combination with RNAi profiling it enables
us to assign a function for C17ORF41 in DNA replication with high confidence,
potentially as a DNA clamp loader.
RNAi studies in D. melanogaster and C. elegans demonstrated that
depletion of individual subunits of protein complexes results in identical RNAi
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phenotypes. The analyses of ten known human protein complexes in this data
set demonstrated similar phenotypic signatures for 97% of the identified subunits
of the same complex (Appendix, Table 14), validating this observation for HeLa
cells. Also, I detected on average 72% of all subunits of these complexes present
in the screened library. The coverage rate of complex subunits yielding the same
phenotype was used as an unbiased measure for detection efficiency in previous
screens (Bjorklund et al., 2006; Gunsalus et al., 2005), and indicates a high
degree of efficiency for this screen. Some of the identified complexes have not
been associated before with a role in cell cycle progression. For example, the
knockdown of all 6 detected coatomer I (COPI) subunits led to a pronounced G1
arrest (Figure 13d). The increase in G1 DNA content may be triggered indirectly
by a primary growth defect upon impairment of COPI-mediated vesicular
transport or may arise from a cell cycle-specific function of COPI. Although the
latter explanation appears to be less likely, I note that recently a cell-cycle
specific function of COPI was demonstrated for nuclear envelope dynamics (Liu
et al., 2003). Noteworthily, I observed two distinct phenotypes for the depletion of
proteasome subunits. The 26S proteasome is a large protease complex that
degrades ubiquitinated proteins, and therefore plays a major role in cell cycle
regulation. Surprisingly, the knockdown of 11 out of 12 detected subunits of the
20S (catalytic) proteasome, which elicits the proteolytic function resulted in a G2
arrest (Figure 13e) while the depletion of all 14 detected subunits of the 19S
(regulatory) proteasome, which has an activating function for the core
proteasome led to a G1 arrest (Figure 13f). The G2 arrest resulting from 20S
proteasome knockdown is consistent with previous reports on the function of
small molecule proteasome inhibitors (Ling et al., 2003). It was therefore
unexpected to observe a different phenotype for the depletion of the 19S
proteasome. This observation suggests that regulation of the proteasome may
have additional roles in cell cycle control. Overall, the high correlation of
phenotypic signatures between complex subunits highlights the potential for the
identification of functional networks in cell cycle regulation, when RNAi data are
compared with protein interaction data.
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High-resolution analysis of phenotypes with altered ploidy
I have demonstrated that profile analysis of cell cycle phenotypes is a powerful
approach to assign putative gene functions. I applied this approach for a more
detailed functional characterisation  of cell division defects. 228 of the 296 genes
associated with a cell division phenotype displayed a change in ploidy. These
genes may have special relevance for cancer biology, because impaired
maintenance of normal ploidy during cell division may lead to genome instability,
a process that has been implicated in early tumorigenesis (Rajagopalan and
Lengauer, 2004; Storchova and Pellman, 2004). Therefore I characterised the
defects underlying these phenotypes in more detail.
In general, there are two major events that will lead to altered ploidy.
These are i) mitotic defects that impair spindle assembly and chromosome
segregation and ii) cytokinesis defects preventing the proper division of the
cytoplasm. I first analysed the phenotypic profiles of three known mitotic and
three known cytokinesis regulators (Figure 14a-d), and used these signatures as
core patterns to group the 228 genes into a cytokinesis defect cluster of 134
genes and a mitotic defect cluster of 94 genes (Figure 14e-f). To evaluate the
reliability of this grouping I analysed 68 phenotypes by video microscopy of a
HeLa cell line stably expressing Histone-GFP. This provided the temporal
resolution needed to determine the cause behind the change in ploidy. 91% of
the predicted mitotic defects displayed defects in prometaphase or metaphase (in
most cases accompanied by an arrest in these phases) from which some cells
exited with unequal or no chromosome segregation. 96% of the predicted
cytokinesis defects displayed normal progression through mitosis until telophase,
when the cells failed to divide the cytoplasm (Appendix, Table 15). Thus, I can
distinguish between gene functions in chromosome segregation and cytokinesis
with high confidence by phenotypic profiling.
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Figure 14 Profile analysis of cell division defects. a-d, Profile comparison
between the known mitotic genes KIF11, STK6, KNTC2 (a,b) and cytokinesis
genes AURKB, PRC1, KIF20A (c,d). e-f, Based on these core patterns the
genes were grouped into a cytokinesis defect cluster (e) and a mitosis defect
cluster (f). Abbreviations in the heat maps are identical to Figure 13.
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Bioinformatic analyses revealed for 190 genes novel functions in
cytokinesis or mitosis (Appendix, Table 15). This includes genes that had been
previously assigned to a very specific role in cell division. For example, the
knockdown of Emi1 (FBXO5) led to a pronounced cytokinesis defect. Emi1 is an
inhibitor of the anaphase promoting complex (APC) (Reimann et al., 2001), which
promotes cyclin degradation and mitotic exit (Morgan, 1999). Previously, Emi1
has been shown to prevent premature APC activation until early mitosis, when
Emi1 is degraded by SCFβTrCP upon phosphorylation by PLK1 (Hansen et al.,
2004; Moshe et al., 2004). The cytokinesis defect upon Emi1 depletion may
indicate either an indirect effect of premature APC activation in early mitosis on
cytokinesis or an additional function of Emi1 as APC inhibitor during cytokinesis.
The latter explanation is supported by two findings. First, although most Emi1 is
degraded in early mitosis, it remains detectable at the spindle poles in late
mitosis and in the midzone/midbody during cytokinesis (Hansen et al., 2004).
Second, anillin and Aurora B, which have essential functions in cytokinesis were
recently identified as APC substrates (Nguyen et al., 2005; Zhao and Fang,
2005). Future studies will be required to determine whether Emi1 may prevent
premature degradation of such proteins through inhibition of APC during
cytokinesis.
Some of the genes I linked to proper chromosome segregation and
cytokinesis may play a role in tumorigenesis by causing genome instability upon
deletion, mutation, misexpression or transactivation. Therefore, I searched the
cytokinesis and mitosis defect clusters for genes previously implicated in
tumorigenesis, and identified 42 putative cancer-associated genes (Appendix,
Table 15). One of these genes (CASC5) was analysed in more detail because of
its striking RNAi phenotype. CASC5 is a fusion partner of the MLL oncogene in
acute lymphoblastic leukemia (ALL) and is upregulated in certain types of lung
cancers (Hayette et al., 2000; Kuefer et al., 2003; Takimoto et al., 2002).
Knockdown of CASC5 resulted in a severe chromosome congression defect
leading to an unequal distribution of chromosomes to daughter cells (Figure 15e-
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h). The cells also progressed significantly faster through mitosis (Figure 15i). This
phenotype is consistent with a defect in kinetochore function, which impairs both
microtubule capture and the activation of the spindle assembly checkpoint.
Interestingly, CASC5 was recently identified in two proteomic studies as a
component of the Mis12 complex of the human kinetochore (as KIAA1570 and
AF15q14), and was suggested to be the putative orthologue of C. elegans KNL-1
and S. cerevisiae Spc105 (Cheeseman et al., 2004; Obuse et al., 2004). The C.
elegans orthologue is required for the targeting of multiple components of the
outer kinetochore, consistent with a “kinetochore-null” phenotype observed upon
RNAi-mediated knockdown (Desai et al., 2003). Thus, the loss-of-function
phenotype reported here shows that human CASC5 is an essential component of
the mammalian kinetochore. Because of the severe chromosome segregation
defect and the potential inactivation of the spindle checkpoint upon knockdown, I
propose that CASC5 plays a role in early tumorigenesis by causing aneuploidy
either by overexpression or transactivation of CASC5 as an MLL fusion partner.
Figure 15 Mitotic phenotype of CASC5 depletion. a-h, High-resolution video
microscopy of chromosome dynamics during mitois in cells transfected with esiRNA
targeting firefly luciferase (a-d) or CASC5 (e-h). The time-lapse sequence starts 60
hours after transfection of a HeLa cell line stably expressing Histone-GFP. Numbers
indicate minutes after the start of the time-lapse sequence. The arrows in h indicate
lagging chromosomes. Scale bar is 5 µm. i, Quantification of mitotic transit times from
prophase to anaphase for CASC5 RNAi and control RNAi using esiRNA targeting firefly
luciferase. 21 mitoses were analysed for CASC5 RNAi and 35 mitoses for control RNAi
starting 60 hours after transfection. Bars indicate means and error bars indicate s.e.m.
The p value was calculated with a two-tailed Mann-Whitney U test.
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Identification of conserved networks for cytokinesis
With the completion of this screen, there are now genome-wide data sets on cell
cycle progression for C. elegans, Drosophila and human tissue culture cells. This
should allow the identification of conserved regulatory pathways and functional
modules. A rich data source for cross-species comparisons is available in
particular for cytokinesis, which has been previously analysed by four large scale
RNAi studies in cultured Drosophila cells (Bettencourt-Dias et al., 2004;
Bjorklund et al., 2006; Echard et al., 2004; Eggert et al., 2004). I therefore
compared these data sets with my screening data to identify conserved
regulatory pathways for cytokinesis. This analysis confirmed the conserved
function of most known motor proteins and central spindle components
implicated in cytokinesis (Appendix, Table 15). Interestingly, the cross-species
comparison yielded genes encoding putative chromatin-binding proteins
implicated in transcriptional repression. For example, knockdown of NCOR2,
which is a co-repressor of various transcription factors (Jepsen and Rosenfeld,
2002) resulted in a cytokinesis defect. A similar phenotype was recently reported
for the D. melanogaster homologue Smr (Eggert et al., 2004) reflecting a high
degree of functional conservation of NCOR2 in cytokinesis. The analysis of
NCOR2 profile neighbours suggested functional interaction with TBL1X and
MLL5 (Figure 16a,b). Bioinformatic analyses identified three putative S.
cerevisiae homologues, SNT1 (NCOR2), SET3 (MLL5) and SIF2 (TBL1X), which
form the histone deacetylase-recruiting SET3 complex (SET3C) for repression of
meiosis-specific genes, including cytokinesis genes (Pijnappel et al., 2001).
Based on this functional data and the protein interaction data of the yeast
homologues I propose a human SET3 complex composed of the NCOR2, MLL5
and TBL1X proteins (Figure 16c) that may regulate the timely expression of
genes involved in cytokinesis. This human SET3 complex is further supported by
physical interaction of TBL1X with NCOR2 in human cells (Guenther et al.,
2000).
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In addition, I propose another transcriptional regulatory complex containing
DKFZp686L1814. The knockdown of this uncharacterised gene also resulted in
defective cytokinesis and a weak mitotic arrest phenotype in this screen. The
putative D. melanogaster homologue MIP120 is a component of a pRB-
containing dMyb repressor complex or dREAM complex (Korenjak et al., 2004;
Lewis et al., 2004). A similar human complex likely exists, because human
MIP120 (DKFZp686L1814) was found to bind to pRB in vitro (Korenjak et al.,
2004). The Drosophila complex was implicated in the regulation of expression of
RB/E2F target genes (Korenjak et al., 2004; Lewis et al., 2004). The RB/E2F
pathway regulates the expression of many cell cycle-related genes including
genes implicated in cytokinesis in Drosophila cells as well as in human cells
(Dimova et al., 2003; Ren et al., 2002). Interestingly, I identified a plant
homologue of DKFZp686L1814 in A. thaliana (Tso1) that is essential for plant
cytokinesis (Hauser et al., 2000). Furthermore, two subunits of the Drosophila
complex (MIP130/twit and CAF1p55) were recently identified as essential genes
for cytokinesis (Echard et al., 2004; Eggert et al., 2004). Hence, this screen
suggests two conserved regulatory transcriptional networks governing proper
cytokinesis, and highlights the potential of comparative analyses of large-scale
screening and proteomic data originating from different model organisms.
Figure 16 Profile analysis of NCOR2, TBL1X and MLL5. a-b, Profile comparison between the three
genes reveals a similar pattern that may indicate functional interaction. c, Graphical depiction of the
yeast SET3 complex with their predicted human homologues NCOR2, TBL1X and MLL5 form a
similar repressor complex like their putative yeast orthologues and a model how this complex
regulates the expression of genes implicated in cytokinesis.
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Conclusion
The genome-wide study identified hundreds of genes with a novel function for
cell cycle progression in HeLa cells. This cell line is the generic experimental
system of many laboratories to study the mammalian cell cycle. As many other
tissue culture cells, HeLa cells are transformed, and it is therefore that genes
might have been missed that are essential in untransformed cells or may have
identified genes with a specialized function in transformed cells. In particular,
steps controlling progression through G1 and entry into S phase are largely
dependent on the cell type and context. Therefore, many of the genes identified
in this category may be specific for HeLa cells and a knockdown in a different cell
line may produce a different or no phenotype. Therefore, these genes should be
carefully validated in other cell lines and in primary cells. While transient RNAi
screens have been technically challenging in primary cells so far because of
inefficient transfection, the emergence of viral infection-based screens will
certainly expand the use of large-scale cell cycle analysis to more physiological
cell types (Moffat et al., 2006). In contrary, DNA replication and mitosis follow
canonical steps that vary little from cell line to cell line. Hence, the identified
genes in these categories present novel players that will likely be generally
important for the mammalian cell cycle in other cell types. Overall, the large
number of newly described gene functions from this study will be a rich starting
point for future work in cell cycle and cancer research.
Importantly, I have demonstrated the potential of phenotypic RNAi profiling
for the assignment of specific functions to novel genes and multi-protein
complexes in combination with bioinformatics, cross-species comparisons and
mining of proteomic data. For model organisms with genome-wide data sets of
protein interactions such as C. elegans, the power of this approach for the
identification of functional modules has been recently demonstrated (Gunsalus et
al., 2005). Therefore, I expect that the comparative analysis of large-scale RNAi
data sets with the growing number of interaction data for mammalian proteomes
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(Rual et al., 2005) will facilitate the identification of additional functional networks
in mammalian cell cycle regulation.
Materials and Methods
Cell-based screening
15 ng esiRNAs in 5 µl TE buffer were mixed with 5 µl OptiMEM (Invitrogen)
containing 0.2 µl Oligofectamine (Invitrogen) in a 384 well tissue culture plate
(Greiner) using a FREEDOM EVO open platform (SN 446, TECAN) with a 8
needle liquid handling system (LiHa), 384 teflon coated steel head (TeMo) with
active 384well wash station and a robot manipulator arm (RoMA). After 20
minutes of incubation at room temperature 1000 HeLa cells in 40 µl medium
(DMEM, 12.5% FBS, 2 mM L-glutamine, 100 U/ml penicillin and 100 µg/ml
streptomycin; Invitrogen) were seeded onto the transfection mix using a
WellMate dispensing system (Matrix).
For DNA content analysis the cells were fixed in ice-cold 100% ethanol for 2
hours, rehydrated for 15 minutes in PBS, and stained for 30 minutes in PBS
containing 10 µg/ml propidium iodide (Molecular Probes) and 100 µg/ml RNase A
(Qiagen). The stained cells were scanned with an Acumen Explorer (TTP
LabTech). The resulting DNA content histograms were manually gated with the
Acumen Explorer software (TTP LabTech) to quantify the cell number and the
percentages of cells with subG1, G1, S, G2/M phase, 4n-8n and 8n DNA content.
For determination of the mitotic index the cells were fixed by adding 50 µl of
8% PFA (Sigma), and incubated for 20 minutes at room temperature. Cells were
permeabilised and blocked in PBS containing 0.1% Triton X-100 (Sigma) and
0.2% fish skin gelatine (Sigma). The cells were incubated for 60 minutes at room
temperature in the presence of primary antibodies against tubulin (Serotec),
phospho-histone H3 (Cell Signaling) and pericentrin (Abcam) at 1 µg/ml, washed
3 times in PBS containing 0.2% fish skin gelatine, incubated for 60 minutes with
73
donkey anti-mouse Alexa647, donkey anti-rabbit Alexa555 and donkey anti-rat
Alexa488 secondary antibodies at 0.4 µg/ml (Molecular Probes), and 1 µg/ml
DAPI (Sigma). After two washes with PBS the cells were stored in 100 µl PBS.
Images were acquired on the CellwoRx system (Applied Precision) equipped with
a 10x objective. 6 images were acquired per well containing typically more than
2000 cells. For the quantification of the mitotic index, he software program
esiImage was used (Miroslav et al, submitted). The mitotic index was calculated
by dividing the number of phosporylated histone H3 positive cells (mitotic cells)
by the number of DAPI positive nuclei (total cell number).
For measurement of cell size the cells were detached by adding PBS
containing 5 mM EDTA (Sigma), incubated for 15 minutes at 37°C, and fixed with
1% PFA. I used the forward scatter (FSC) determined by FACS analysis with a
FACSCalibur (BD Biosciences) using CellQuestPro software as a measure for
cell size.
Normalisation of raw data and hit selection
Many screens select hits as outliers of a population using mean centring of an
entire population (e.g. all wells of a 384 well plate) typically by determining a z
score. This value is derived by first subtracting the population mean from an
individual score and then dividing the difference by the standard deviation of the
entire population. Therefore, the z score is a dimensionless value representing
the distance between an individual score and the population mean in units of the
standard deviation. That means a negative z score indicates a score below the
mean, and a positive z score a score above the mean.
In this screen I used a very similar approach for hit selection. In contrast to
z score calculation, I used the mean and standard deviation of 8 negative
controls (i.e. 4 esiRNAs targeting firefly and 4 esiRNAs targeting renilla
luciferase) per plate instead of the entire plate. There rationale for the use of
controls for normalisation is the better comparability between the primary and
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secondary screens. In the primary screen it is likely that most targeted genes had
no effect on cell cycle progression, and behaved essentially like negative
controls. However, in the secondary screen a z score calculation would have
been not applicable because most genes already represented outliers.
Therefore, the use of negative controls for normalisation appears to be more
sophisticated for large-scale studies with multiple passes.
In the primary screen I used an averaged normalised value > +3
(indicating high significance) for the G1, S, G2/M or polyploidy (8n) DNA content
for hit selection. In the secondary screen I scored 1307 primary hit as verified for
an averaged normalised value > +2 (indicating statistical significance). In
addition, I scored 82 primary hits with an averaged normalised values +1.5 >>
+2.0 (approaching statistical significance) in the secondary screen as verified low
confidence hits that are highlighted in yellow (Appendix, Table 11).
Clustering analyses
Hierarchical clustering of the 1389 phenotypic profiles was performed with
EPCLUST (http://ep.ebi.ac.uk/EP/EPCLUST) using correlation measure based
distances and average linkage clustering. As input for EPCLUST I used the
averaged normalised values of the nine determined parameters that were cut off
at +20 and –20.
Time-lapse microscopic assay
Transfections were performed as described above using a HeLa cell line stably
expressing Histone-GFP. Time-lapse fluorescence microscopy for 68 cell division
defects was performed by acquiring frames every 6 minutes over a 48 hours
period starting 24 hours after transfection using a Cell^R system (Olympus)
equipped with a 10X objective and an incubator chamber (Evotec). All movies
are provided in the movie set 2 of the appendix.
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For high-resolution time-lapse imaging, HeLa cells stably expressing Histone-
GFP were grown and transfected in 8-well LAB-TEK II chambered cover glass
(Nalge Nunc International). Cells were imaged 48 hours after transfection on a
DeltaVision RT (Applied Precision) system heated at 37°C and equipped with an
Olympus 60x objective and a CoolSnap HQ CCD camera (Roper Scientific). Z-
stacks (30 sections, 1 µm apart, 35ms exposure per section, 10% ND filter) were
acquired every 10 minutes over 24 hours. Images were computationally
deconvolved using the SoftWorX software package version 3.4.4 (Applied
Precision) and shown as maximal projections.
Analysis of the expression status of candidate genes
For 1566 of the 2149 hit genes identified in the primary screen I tested the
presence of a transcript in HeLa experimentally by RT-PCR. RNA from HeLa
cells was extracted using the RNeasy Mini Kit (Qiagen) including a DNaseI
digest. cDNA was synthesized with SuperScript III reverse transcriptase
(Invitrogen) using an oligo(dT) primer (Invitrogen). PCR was performed with
transcript-specific primers. PCR products were separated on a 2% agarose gel. I
detected a single RT-PCR product of the predicted size for 1448 hit genes (92%).
The expression status of 441 hit genes, for which no transcript-specific primers
were available was analysed in silico. For this purpose I downloaded expression
data of the NCI60 cell lines (including HeLa) from the SYMATLAS database
(http://wombat.gnf.org/index.html) (Su et al., 2002). Using the A/P calls as an
indicator for the presence of a transcript I identified 251 genes expressed in
HeLa (57%). I note that most of the 190 genes flagged absent in HeLa had a
relatively low computed RMA expression value in all other NCI60 cell lines and
also in other tissues I tested in silico. Therefore, the in silico determined number
of expressed hit genes might be artificially low in comparison to the experimental
results because A/P calling might have excluded low-abundant transcripts. The
expression status of 142 genes could not be tested, because neither transcript-
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specific primers nor gene expression data were available. The expression status
of the final 1389 genes reported is indicated (Appendix, Table 11).
Bioinformatic analyses
For functional annotation I performed a batch download of gene ontology data
from the public database SOURCE (http: / /smd.stanford.edu/cgi-
bin/source/sourceBatchSearch) (Diehn et al., 2003). In addition, I searched the
P r o t e o m e  B i o K n o w l e d g e ®  L i b r a r y
(http://www.proteome.com/control/tools/proteome) for genes that had no
gene ontology entry in SOURCE. Based on their annotations I grouped the
genes manually into the following categories: metabolism (anabolic and catabolic
pathways, including glycosylation), transcription (general transcription, i.e. RNA
polymerase subunits), transcriptional regulation (positive and negative regulation
of transcription), translation (ribosomal proteins, biogenesis of ribosomes,
translation factors), RNA metabolism (mRNA splicing, RNA modication and
degradation), transport (channels, membrane trafficking, nucleo-cytosolic
transport), (de)phosphorylation (kinases, phosphatases and their accessory
proteins), (de)ubiquitination (proteins implicated in ubiquitin metabolism), protein
folding (e.g. chaperons, chaperonins), cytoskeleton (components and modulators
of the actin/microtubule cytoskeleton, including motor proteins), other (all genes
that did not match any of the categories above) and unknown (genes without
annotations). These annotations are indicated (Appendix, Table 11).
For the comparison of my data with previous cell cycle RNAi screens in D.
melanogaster (Bettencourt-Dias et al., 2004; Bjorklund et al., 2006; Echard et al.,
2004; Eggert et al., 2004) (Appendix, Table 13) I first identified the putative
homologues of the reported Drosophila genes among the 1389 hit genes. For
this purpose I either used the published information of the human orthologues in
the corresponding screening papers or the predicted human orthologues in the
FLIGHT database (http://flight.licr.org/) (Sims et al., 2006). I identified putative
orthologues with similar phenotypes manually by comparing the phenotypic
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signatures with the published fly RNAi data. I excluded all genes from analyses
for which the same phenotypic category did not exist in both studies, e.g. for
comparing my data with (Bjorklund et al., 2006) I excluded all of S phase arrest
phenotypes because S phase DNA content was not determined in this study.
Likewise, I excluded all genes of (Bjorklund et al., 2006) that had a cell size
phenotype only, because cell size was not a primary screening parameter in my
study.
For the identification of the homologues of C17ORF41, DKFZp686L1814,
MLL5, NCOR2  and TBL1X I used the BLAST similarity of the amino acid
sequences of the corresponding proteins that were refined with the Smith-
Waterman algorithm as implemented in the Proteome BioKnowledge® Library.
For TBL1X I identified S. cerevisae SIF2 (E=1e-40), for MLL5 I identified S.
cerevisiae SET3 (E=9e-11), and for NCOR2 I identified S. cerevisiae SIF2
(E=3e-13) as the most likely homologues. All three homologues were verified by
reciprocal BLAST. Likewise, I identified for human DKFZp686L1814 the putative
D. melanogaster homologue MIP120 (E=9e-49) and the A. thaliana homologue
Tso1 (E=3e-20). The GenBank accession numbers of the amino acid sequences
are as follows: human MLL5 (NP_891847), S. cerevisiae (CAA82101), human
NCOR2 (NP_006303), S. cerevisae SNT1 (CAC42983), human TBL1X
(NP_005638), S. cerevisiae SIF2 (CAA85058), human DKFZp686L1814
(NP_919258), D. melanogaster MIP120 (NP_610879), A. thaliana Tso1
(NP_566718), human C17orf41 (NP_079133) and human RFC1 (NP_002904).
Previous implications of genes exhibiting a mitotic/cytokinesis defect upon
knockdown in cancer were identified by literature search in PubMed
(http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?DB=pubmed) or by data
mining in the Proteome BioKnowledge® Library and are indicated with a
reference (Appendix, Table 15).
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Chapter 5: Development of BAC transgenesis
technology in cultured human cells
In the previous chapters I described loss-of-function studies in human tissue
culture cells. Here I demonstrate that expression of murine bacterial artificial
chromosomes in human cells provides a reliable method to create RNAi resistant
transgenes. This strategy should be applicable to all eukaryotes and should
therefore be a standard technology for confirming the specificity of RNAi. I show
that this technique can be extended to allow the creation of tagged transgenes,
expressed at physiological levels, for the further study of gene function.
Concept of BAC transgenesis
I propose a novel technology circumventing both the problem of inefficient
homologous recombination and the unphysiological expression obtained with
cDNA constructs in mammalian cells by expressing an orthologous gene from a
closely-related species including its regulatory sequences carried on a bacterial
artificial chromosome (BAC). In contrast to cDNA expression constructs, the
transfer of these large segments of genomic DNA speeds up the generation of
transgenic cell lines, allows physiological expression and the generation of
alternatively spliced variants of the transgene. Mouse geneticists have
successfully utilized these advantages of large constructs for the generation of
transgenic animals. For many years cDNA constructs were used to generate
transgenic mice. Because of position effects many founder lines needed to be
tested to identify one with the appropriate expression pattern. The development
of BAC technology for generation of transgenic mice has alleviated this problem
to a large extent. Coupled with the development of methodology to specifically
mutate large DNA molecules (Zhang et al., 1998), now termed recombineering
(Copeland et al., 2001; Muyrers et al., 2001), BACs are now the preferred choice
to generate transgenic animals (Giraldo and Montoliu, 2001; Magdaleno and
Curran, 1999).
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Here I establish BACs as rescue constructs for RNAi in mammalian tissue
culture cells (Figure 17). The use of BACs carrying the orthologous gene from a
closely related species confers RNAi resistance to the transgene. The cross-
species strategy also abolishes the need for introducing point mutations or
replacing the 3’UTR. I established this approach for human tissue culture cells by
the use of mouse BACs. This experimental concept provides a standardized
platform to check the specificity of any particular RNAi experiment. In addition,
this technology mimics homologous recombination by depleting an endogenous
gene via RNAi and replacing it with a transgene while maintaining normal gene
expression. Therefore, this approach helps to turn mammalian tissue culture cells
into a real genetic system, that should be useful for protein localisation studies,
structure/function analyses and the purification of protein complexes.
Figure 17 Experimental strategy of RNAi rescue by BAC transgenesis. (RFP –
red fluorescent protein, Kan/neor – kanamycin/neomycin resistance gene, Cmr –
chloramphenicol resistance gene, ori – origin of replication, BB – BAC backbone,
CSI-BAC – cross-species RNAi rescue-BAC)
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Results and Discussion
Generation of transgenic human cell lines
The mouse genome-sequencing project has produced overlapping large genomic
constructs, including libraries of bacterial artificial chromosomes. These
constructs are typically larger than 100 kb and most genes are available on a
single BAC. Therefore, these constructs are well suited to express genes within
their physiologically genetic “environment”. The proportion of human genes
without any homologue currently detectable in the mouse genome is less than
1% (Waterston et al., 2002). Therefore, the described methodology should be
generally applicable to almost all human genes. Based on the BAC coverage and
gene size in mouse, I estimate that BACs containing the genomic sequence of a
gene and 20 kb of upstream sequence should be available for more than 90% of
all genes. These BACs are available through several public resources and can
be rapidly identified with open-access databases.
To allow rapid assessment of transfection efficiency and selection for
stable integration of the mouse BAC in human cells, I designed a universal
cassette carrying a neomycin/kanamycin selection marker and an RFP marker
that carries homologous sequences to replace the chloramphenicol cassette on
the BAC backbone by recombineering (Copeland et al., 2001; Muyrers et al.,
2001). The incorporation of this cassette replaces the internal chloramphenicol
resistance gene, thereby allowing a simple selection scheme to obtain
successfully modified BACs, monitoring kanamycin resistance and
chloramphenicol sensitivity (Figure 17). All positive colonies analysed had
integrated the cassette at the intended locus, demonstrating the efficiency and
simplicity of this approach. By using the universal cassette the BAC modification
can be streamlined and performed within two days, allowing rapid processing of
many different BACs.
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The large size of BAC constructs makes them more difficult to transfect
into mammalian cells than cDNA constructs. To monitor and optimise the
transfection efficiency I included the RFP gene in the replacement cassette.
Based on the expression of RFP monitored 48 hours after transfection, I obtained
an average transfection efficiency of ~2% with standard lipofection reagents,
which was sufficient to obtain many clones that stably express the transgene
(Figure 18).
I modified two BACs carrying the mouse orthologues of the two human
genes SNW1 and DNAJA3. SNW1 is a transcription co-activator and pre-mRNA
splicing factor (Zhang et al., 2003), that I identified to be essential for cell division
in human cells in the pilot RNAi
screen (see chapter 3) (Kittler
et al., 2004). I showed that
RNAi-mediated depletion of
SNW1 in HeLa cells resulted in
spindle and cytokinesis defects
suggesting a link between
splicing and cell division. In
order to test the specificity of
this provocative knockdown
phenotype I generated a BAC
transgenic cell l ine that
expresses the mouse SNW1
gene. In order to test for
alternative splicing of a murine
gene in human cells I chose the
mouse orthologue of the human gene DNAJA3, a heat shock protein for which
alternatively spliced transcripts have been reported (Yin and Rozakis-Adcock,
2001).
Figure 18 Expression of mouse transgenes in
human cells. Overlay of phase contrast with
RFP fluorescence images taken from HeLa
cells 48 hours after transfection with a
modified BAC. Cells were assessed for red
fluorescence indicating expression of RFP
from the incorporated BAC. The bar is 50 µm.
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Alternative splicing and expression of transgenes
To test whether alternative splicing of the murine DNAJA3 gene (mDNAJA3)
would take place in human HeLa cells I designed a primer pair specific for two
isoforms, which should generate two PCR fragments of different length. RT-PCR
using cDNA derived from HeLa cells that have stably integrated a BAC carrying
mDNAJA3 revealed the expression of two products with the expected length for
both splice isoforms, indicating successful alternative splicing of murine genes in
human cells (Figure 19).
In order to analyse and compare the expression levels of an endogenous
human gene with the mouse transgene in human cells I developed a PCR-based
assay for SNW1. I chose a single primer pair that perfectly matches to both
human (hSNW1) and mouse (mSNW1) cDNA. Both, the human and the mouse
fragments will be amplified proportional to their starting template number.
Figure 19 Alternative splicing of mouse transgenes in human cells. (a)
Detection of expression and alternative splicing of mDNAJA3 by RT-PCR. Lane
1: The two bands (495 bp and 377 bp) amplified from cDNA of HeLa cells
transfected and selected for a BAC carrying mDNAJA3 representing the two
splice isoforms. Lane 2: negative control (cDNA from wildtype HeLa cells). Lane
3: non-template control. M: marker.
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Figure 20 Physiological expression of mouse transgenes in human cells. a,
RT-PCR/SfaNI digestion assay used for the comparison of hSNW1 and
mSNW1 expression. The annealing regions of the primers that perfectly
match both human and mouse sequences are indicated. Nucleotides that
differ in the human and mouse sequence are shown in red. The SfaNI
restriction site is indicated by the small arrow. b, Expression levels of hSNW1
and mSNW1 in transgenic cells. The comparison of the band intensities
indicates relative expression levels of hSNW1 and mSNW1. Lane 1:
Undigested 161 bp fragment from the same clone depicted in lane 2. Lane 2 -
11: SfaNI digestion products of a 161 bp fragment amplified from cDNA of 10
clones from HeLa cells transfected and selected for a BAC carrying mSNW1.
The upper band represents the uncut human-specific fragment, the lower
band the mouse–specific fragment. Lane 12: Digested fragment generated
from cDNA of wildtype HeLa cells. M: Marker.
a
b
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I used a restriction fragment length polymorphism (RFLP) to distinguish between
the expression from the human gene and the mouse transgene (Figure 20a). The
analysis of ten transgenic clones revealed that nine out of ten clones expressed
mSNW1 at almost identical levels as hSNW1 (Figure 20b).
Although regulatory elements such as CpG islands may differ in
organisation between human and mouse (Cuadrado et al., 2001), gene
expression patterns are strongly conserved for most genes of both species.
Therefore, I expect that most mouse genes should be expressed at similar levels
as their human orthologues. Also, most alternative splicing events are likely to be
conserved between mouse and human (Thanaraj et al., 2003).
Only very few genes of mouse and human should not be fully
interchangeable, as they are either species-specific or display significant
differences in protein structure and function. Species-specific gene expression in
human and mouse is restricted to some genes involved in e.g. immune and
xenobiotic response, and for polymerase I-dependent transcription of rRNAs
(Heix et al., 1997; Rehli, 2002; Xie et al., 2000). In such cases, one could
alternatively rescue with a BAC carrying the same gene containing silent
mutations or a modified 3'UTR. This could be realized with the experimental
protocols described here, and would require the generation of a specific
construct for the recombineering step. This strategy would be more time-
consuming than the described modification of the BAC backbone, but would still
allow physiological expression and alternative splicing of the gene of interest,
and therefore would be preferable over a cDNA rescue approach.
Knockdown specificity in transgenic cell lines
To test the human-specific knockdown of SNW1 in transgenic cells I generated
an esiRNA targeting a sequence fragment of the 3’UTR of hSNW1. I tested the
silencing efficiency of this esiRNA in wildtype HeLa cells by quantitative PCR and
found a reduction of 90% at the mRNA level (Figure 21a).
To check the specific knockdown of hSNW1 in the transgenic clones after
esiRNA transfection I analysed the relative expression levels after transfection of
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the human-specific esiRNA by using the same PCR-RFLP assay described
above. I observed a strong reduction of the human-specific product compared to
the mouse-specific product (Figure 21b). These results indicate a specific and
efficient knock down of the human but not of the murine mRNA. I thus conclude
that a mouse gene expressed from a BAC escapes RNAi triggered by human-
specific siRNAs.
The RNAi resistance of the rescue gene is based on sequence differences
between the transgenic mRNA and the siRNA(s) perfectly matching the
endogenous mRNA. The number of nucleotide differences between mouse and
human transcripts are in a range, which allows the design of siRNAs silencing
only the human homologues. In particular the 3’ UTR may be useful for this
Figure 21 RNAi resistance of mouse transgenes in mammalian cell lines. a,
Knockdown of hSNW1 in transgenic HeLa cells. hSNW1 expression after
transfection of esiRNAs targeting hSNW1 and firefly luciferase. hSNW1 mRNA
expression was quantified two days after transfection. Expression levels were
normalised against hSNW1 expression of cells transfected with esiRNA
targeting firefly luciferase. Error bars represent s.d. b, Expression levels of
hSNW1 and mSNW1 in transgenic HeLa cells. Lane 1 and 2: SfaNI digestion
products of the 161 bp fragment amplified from cDNA of transgenic HeLa cells
transfected with esiRNA targeting firefly luciferase (lane 1) and hSNW1 (lane 2).
Note the change of relative band intensities indicating the specific knockdown of
hSNW1. Lane 3 and 4: Undigested 161 bp fragment amplified from cDNA of
transgenic HeLa cells transfected with esiRNA targeting firefly luciferase (lane
3) and hSNW1 (lane 2). Lane 5: non-template control. M: marker.
a b
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purpose, because this mRNA region exhibits an extremely low level of sequence
similarity between mouse and human compared to coding sequences. This may
be critical, because imperfectly matching siRNAs can potentially hit multiple
mRNAs based on micro-homology at the 5' end of the antisense strand and/or
inhibit translation in a miRNA-like manner (Doench et al., 2003; Jackson and
Linsley, 2004). Because of its high degree of specificity (Kittler et al., 2004)
esiRNA is an excellent source for running down the endogenous gene while
leaving the transgene expression unchanged. Hence, an independent esiRNA
generated from the coding region of hSNW1 that shares 92% sequence identity
with mSNW1 resulted in a similar reduction of hSNW1 transcripts while not
affecting mSNW1 expression (data not shown).
Rescue of an RNAi phenotype
I identified SNW1 as an indispensable gene for cell division in HeLa cells (see
chapter 3) (Kittler et al., 2004). The knockdown of SNW1 results in mitotic arrest
and cytokinesis defects followed by apoptosis. To test whether the expression of
the murine orthologue reverts the deleterious effect of the knockdown phenotype
of human SNW1, I transfected an esiRNA targeting hSNW1 into wildtype and
mSNW1 transgenic HeLa cells. Transfection of human-specific esiRNA into
wildtype cells resulted in markedly lower cell density with many dead cells 96
hours after transfection. In contrast HeLa cells expressing mSNW1 grew
essentially like wildtype cells transfected with esiRNA targeting firefly luciferase
(Figure 22a-e). The analysis of the mitotic spindle morphology further revealed
the reversion of the spindle defect phenotype in transgenic cells in comparison to
wildtype cells upon depletion of hSNW1 (Figure 22f-j). I conclude that the
expression of the mouse orthologue of a targeted human gene rescues the RNAi
phenotype of SNW1. I have therefore confirmed the essential function of SNW1
and its cell division phenotype in HeLa cells.
87
  
Figure 22 Rescue experiment. a-d, Phase contrast microscopic images of
wildtype HeLa cells (a, c) and BAC transgenic HeLa cells expressing mSNW1
(b, d) 96 hours after transfection with esiRNA targeting hSNW1 (c, d) and
firefly luciferase as negative control (a, b). (e) Effect on cell viability of esiRNA
targeting hSNW1. Cells were assayed 96 hours after transfection. Reduction
of cell viability as determined with the WST-1 assay normalised against the
negative control luc (esiRNA directed against firefly luciferase). f-i,Wildtype
HeLa cells (f, h) and BAC transgenic HeLa cells expressing mSNW1 (g, i)
were transfected with esiRNA targeting hSNW1 (h, i) and firefly luciferase as
negative control (f, g) and imaged by 3D deconvolution microscopy 48 hours
after transfection for tubulin (green) and DNA (blue). Bars are 100 µm (a-d) or
5 µm (f-i). (J) Frequency of aberrant spindles. Tthe frequency of abberant
spindles 48 hours after transfection was counted for 50 mitotic cells per cover
slip. Error bars represent s.d. (mSNW1-BAC – HeLa cells that have stably
integrated the BAC carrying mSNW1, luc – esiRNA targeting firefly luciferase,
hSNW1 – esiRNA targeting hSNW1)
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This data shows that cross-species BAC transgenic cell lines allow easy, quick
and efficient confirmation of RNAi phenotypes. I demonstrated the proof-of-
concept for the human-mouse-system. In principle, this concept should be
applicable for all closely related species among the eukaryotes, which are
subject to RNAi-based functional studies, e.g. C. elegans - C. briggsae and D.
melanogaster – D. yakuba.
BAC gene-tagging and RNAi rescue
In addition to loss-of-function and gain-of-function analyses, protein localisation
studies are an important tool in functional genomics. The use of green
fluorescent protein as a fusion tag has added great value to protein localisation
studies (Chalfie et al., 1994). In addition to localising a protein to a cell
compartment it also allows to study the dynamic behavior of a protein in living
cells through the use of time-lapse video microscopy. In budding yeast almost all
ORFs have been GFP-tagged to provide a global view on protein localisation in
this organism (Huh et al., 2003). Importantly, in this study the ORFs were
targeted via homologous recombination to allow expression from their
endogenous promoters. Hence, the fusion proteins were expressed at
physiological levels and therefore mislocalisation due to overexpression of
proteins was avoided.
In human cells large scale GFP tagging projects have started to provide an
inside into the localisation of the mammalian proteome (Simpson and Pepperkok,
2003). In these studies cDNA constructs are used to express the genes from viral
promoters. As a consequence, the GFP-tagged genes are typically expressed at
unphysiological levels, that can lead to phenotypes and mislocalisation (Garrido
et al., 2003; Lisenbee et al., 2003; Szebenyi et al., 2002). Furthermore, the
expression of cDNAs precludes the visualization of alternatively spliced variants,
which may show a different localisation. The use of modified BACs may
overcome these limitations (Figure 23a).
To test whether BAC-GFP-tagging can be combined with cross-species
RNAi rescue and thereby allow functional expression of the tagged protein in the
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absence of the endogenous protein, a GFP-tag was inserted at the C-terminus of
the mouse homologue of the C. elegans SPD2 protein(Pelletier et al., 2004).
Consistent with the localisation pattern of SPD2 in C. elegans and its role in
spindle assembly in the early embryo (Pelletier et al., 2004) (Kemp et al., 2004),
the human homologue of SPD2 also localises to the centrosome (Pelletier et al.,
2004).
As was observed for the mSNW1 clones, most mSPD2 clones expressed
the transgene at equivalent levels compared to the endogenous human gene and
transfection of human specific siRNA resulted in predominant silencing of the
human transcript (data not shown). Immunofluorescence analysis of a selected
cell line revealed that SPD2-GFP fluorescence was restricted to the mitotic
spindle poles, suggesting that the tagging does not interfere with the subcellular
localisation of SPD2 (Figure 23b). Next, the functional complementation of the
Figure 23 BAC-tagging for functional studies in mammalian cell lines. The
scheme of the procedures is illustrated in (a). (TAG – fusion-sequence to
investigate gene function (e.g. green fluorescence protein), IRES – internal
ribosome entry site, neo – kanamycin/neomycin resistance gene, BAC –
bacterial artificial chromosome, r –resistance gene of the BAC, BB – BAC
backbone). b, HeLa cell line containing the mouse SPD2 BAC tagged with GFP
stained for DNA (Blue), microtubules (Red) and GFP (Green). Note the
presence of mSPD2-GFP on both poles of the mitotic spindle. c, Wild-type
HeLa cells or HeLa cells stably expressing the mSPD2 BAC tagged with GFP
submitted to hSPD2 RNAi. Note that the percentage of mitotic cells present in
HeLa mSPD2 BAC containing cells is reduced compared to that observed in
WT cells. Error bars represent s.d.
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human SPD2 gene with the murine SPD2-GFP was tested. Consistent with it’s
role in spindle assembly in C. elegans, the depletion of SPD2 in HeLa cells by
RNAi leads to an increase in the mitotic index of cells from about 5% in control
transfected cells (data not shown) to about 25% in cells treated with siRNA
against SPD2 (Figure 23c). In contrast, in cells expressing the mSPD2-GFP
transgene, the mitotic index dropped considerably towards wild type levels
(Figure 23c).
In addition to GFP tagging the expression of TAP tagged fusion genes from
BACs was established (data not shown). Recently, this approach was used for
the identification of interaction partners of the centromere-associated protein
shugoshin (Riedel et al., 2006).
Conclusion
In summary, I demonstrated that gene tagging by BAC recombineering can be
combined with RNAi to mimic homologous recombination in mammalian tissue
culture cells enabling a variety reverse genetic approaches. I demonstrated the
utility of this approach in RNAi rescue experiments. In particular the ability to
introduce tagged transgenes on their own promoter, and to remove the
endogenous gene function, heralds the era of mammalian tissue culture cell
genetics.
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Materials and Methods
BAC engineering
The BACs RP23-285E19 (harboring mSNW1), RP24-181C3A (harboring
mDNAJA3) and RP24-351L1 (harboring mSPD2) were obtained from the
BACPAC Resources Center (http://bacpac.chori.org). Neo/Kanr-RFP and EGFP-
IRES-Neo cassettes were PCR amplified with primers with 50 nucleotides of
homology to the targeting sequence (Appendix, Figure 1). Recombineering of the
BACs was performed as described previously (Zhang et al., 2000).
BAC transfection
HeLa cells were seeded 16 hours before transfection into 6 cm dishes with a
density of 700,000 cells per well in 5 ml medium (DMEM, 10% FBS, 2 mM
glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin). Transfection was
performed with Effectene (Qiagen) using 1 µg supercoiled BAC DNA, purified
with the large-construct kit (Qiagen). The cells were transferred 24 hours later on
10 cm dishes and cultivated in selection medium containing 750 µg/ml geneticin
(GIBCO).
Detection of DNAJA3 and SNW1 expression
RNA was extracted from transgenic HeLa cells using the RNeasy Mini Kit
(Qiagen). cDNA was synthesized with SuperScript II reverse transcriptase
(Invitrogen) and expression of the transgenes was detected by PCR using the
primers 5’-AGTCACCCACACAAGCACTG-3’/5’-AAGCTGTAAGCCGGGTCTTT-
3 ’  (D N A J A 3 )  and 5’-TGACCAAAGGCTCTTCAACC-3’/5’-
CTGGACAAGGACATGTATGGTG-3’ (SNW1). The SNW1 PCR product was
digested with SfaNI (New England Biolabs) and products were separated on a
3% agarose gel.
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esiRNAs
An esiRNA targeting the 3’ untranslated region (3’UTR) fragment from hSNW1
was synthesized. The template for in vitro transcription of firefly luciferase was
generated as described elsewhere (Kronke et al., 2004).
Quantification of hSNW1 knockdown
Wildtype HeLa cells and cells expressing mSNW1 were seeded 16 hours before
transfection into 12 well plates with a density of 20,000 cells per well in 1 ml
medium (DMEM, 10% FBS, 2 mM glutamine, 100 U/ml penicillin, 100 µg/ml
streptomycin). Transfection was performed with oligofectamine (Invitrogen) using
2.5 µg esiRNA targeting hSNW1 or firefly luciferase. Cells were harvested 48
hours after transfection and RNA extraction and cDNA synthesis were performed
as described above.
hSNW1 mRNA expression was quantified by qRT-PCR using the Brilliant
SYBR Green system and the Mx4000 Multiplex Quantitative PCR system
(Stratagene), using the primers 5’-TCCTAATCCTCGGACTTCCA-3’/5’-
GGGCCATATCTTTACCACCTC-3’. Expression levels of hSNW1  in cells
transfected with hSNW1-specific esiRNA were normalised against the expression
level of cells transfected with esiRNA targeting firefly luciferase.
Rescue experiment
Wildtype HeLa cells and cells expressing mSNW1 or mSPD2 were seeded 16
hours before transfection into 96 well plates with a density of 2000 cells per well
in 100 µl medium. Transfections were performed using 50 ng esiRNA (hSNW1),
or 40 nM siRNA (hSPD2) and oligofectamine (Invitrogen). The sequences of the
h S P D 2  s iRNA were 5’GGAAGACAUUUUCAUCUCUtt-3’ and
5’AGAGAUGAAAAUGUCUUCCtt-3’. Because of three mismatches to this
sequence, the mouse transcript is not significantly silenced by this siRNA.
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Cell viability was measured 96 hours after transfection using the WST-1 assay
(Roche Diagnostics). Mitotic cells were counted 36 hours post transfection.
For visualization of the mitotic spindles HeLa cells grown on coverslips were
transfected as described above. 48 hours after transfection the cells were fixed
and permeabilized in methanol at -20°C for 8 minutes. Cells were washed with
PBS and incubated 10 minutes in PBS containing 0.2% fish skin gelatin
(PBS/FSG, Sigma). Cells were incubated for 20 minutes with a mouse
monoclonal antibody against tubulin directly labeled with FITC (DM1, Sigma) and
mounted in the presence of DAPI (1 µg ml-1) to visualize chromatin. Three-
dimensional data sets were acquired on a DeltaVision imaging system (Applied
Precision) equipped with an Olympus IX70 microscope. Images were
computationally deconvolved using the SoftWork software package and shown
as two-dimensional projections.
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Outlook
In two large-scale RNAi screens I identified a panoply of genes with a novel
function for cell cycle progression in human HeLa cells. These genes present
starting points for the elucidation of the molecular basis of various aspects of cell
cycle regulation. I have already started to further characterise several genes
implicated e.g. in DNA replication, spindle assembly, chromosome segregation
and cytokinesis (see chapters 3 and 4). For the systematic analysis of a larger
set of these genes, BAC transgenesis will be employed to first study the dynamic
localisation of the corresponding proteins. For that purpose, large-scale tagging
of the identified genes with GFP has been initiated. The generated transgenic
cell lines will be analysed by video microscopy to study the specific localisation of
these proteins during interphase and cell division, which may deliver further
insights into the functions of these genes. Because the gene fusion tag used for
localisation can also be used for tandem affinity purification, the identification of
interaction partners will be next step to place these genes into functional
networks. In combination with bioinformatics, cross-species comparisons and the
mining of existing protein interaction data (as already demonstrated in chapter 4)
these analyses will be the basis for a coherent systems model of the mammalian
cell cycle.
Furthermore, it would be very interesting to test the role of the identified
genes in different cancer cell lines and in untransformed cells. This analysis
should uncover genes that have a cancer-specific function and identify the
differentiation or apoptosis block driving the cells into self-renewal. For that
purpose, several cancer cell lines should be functionally profiled by RNAi, in
addition to gene expression profiling of patient material and the analysis of tissue
arrays with specific antibodies. Some of these genes could represent excellent
novel diagnostic and/or therapeutic cancer targets. Thus, in the long run I expect
that this work will advance our understanding of the human cell cycle and will
provide novel concepts for the treatment of human disease.
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